Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Schizophr Res

Retrieve available abstracts of 697 articles:
HTML format
Text format



Single Articles


    February 2017
  1. CRESPO-FACORRO B, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, Valdizan EM, et al
    Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1year study.
    Schizophr Res. 2017 Feb 17. pii: S0920-9964(17)30059.
    PubMed     Text format     Abstract available


  2. CANTILLON M, Prakash A, Alexander A, Ings R, et al
    Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder.
    Schizophr Res. 2017 Feb 16. pii: S0920-9964(17)30056.
    PubMed     Text format     Abstract available


  3. LEWINE R, Martin M, Hart M
    Sex versus gender differences in schizophrenia: The case for normal personality differences.
    Schizophr Res. 2017 Feb 16. pii: S0920-9964(17)30102.
    PubMed     Text format     Abstract available


  4. QUIDE Y, Ong XH, Mohnke S, Schnell K, et al
    Childhood trauma-related alterations in brain function during a Theory-of-Mind task in schizophrenia.
    Schizophr Res. 2017 Feb 15. pii: S0920-9964(17)30083.
    PubMed     Text format     Abstract available


  5. ITTIG S, Studerus E, Heitz U, Menghini-Muller S, et al
    Sex differences in prolactin levels in emerging psychosis: Indication for enhanced stress reactivity in women.
    Schizophr Res. 2017 Feb 14. pii: S0920-9964(17)30081.
    PubMed     Text format     Abstract available


  6. RODRIGUES R, Anderson KK
    The traumatic experience of first-episode psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2017 Feb 14. pii: S0920-9964(17)30058.
    PubMed     Text format     Abstract available


  7. WEINSTEIN Y, Gelkopf M, Roe D, Levine SZ, et al
    The effect of different terror exposures on the course of schizophrenia: A twenty-year follow-up of a random sample.
    Schizophr Res. 2017 Feb 14. pii: S0920-9964(17)30075.
    PubMed     Text format    


  8. LOPEZ-GIMENEZ JF, de la Fuente Revenga M, Ruso-Julve F, Saunders JM, et al
    Validation of schizophrenia gene expression profile in a preclinical model of maternal infection during pregnancy.
    Schizophr Res. 2017 Feb 12. pii: S0920-9964(17)30076.
    PubMed     Text format    


  9. OESTREICH LK, Lyall AE, Pasternak O, Kikinis Z, et al
    Characterizing white matter changes in chronic schizophrenia: A free-water imaging multi-site study.
    Schizophr Res. 2017 Feb 10. pii: S0920-9964(17)30077.
    PubMed     Text format     Abstract available


  10. GEISER E, Retsa C, Knebel JF, Ferrari C, et al
    The coupling of low-level auditory dysfunction and oxidative stress in psychosis patients.
    Schizophr Res. 2017 Feb 9. pii: S0920-9964(17)30073.
    PubMed     Text format     Abstract available


  11. ROBERTS RC
    Postmortem studies on mitochondria in schizophrenia.
    Schizophr Res. 2017 Feb 9. pii: S0920-9964(17)30070.
    PubMed     Text format     Abstract available


  12. BRIEND F, Leroux E, Delcroix N, Razafimandimby A, et al
    Impact of rTMS on functional connectivity within the language network in schizophrenia patients with auditory hallucinations.
    Schizophr Res. 2017 Feb 8. pii: S0920-9964(17)30067.
    PubMed     Text format     Abstract available


  13. MEZQUIDA G, Cabrera B, Bioque M, Amoretti S, et al
    The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30060.
    PubMed     Text format     Abstract available


  14. LY D, DeLisi LE
    Can antibiotics cause a psychosis?: Case report and review of the literature.
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30054.
    PubMed     Text format     Abstract available


  15. MUELLER DR, Khalesi Z, Benzing V, Castiglione CI, et al
    Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30050.
    PubMed     Text format     Abstract available


  16. GLAUSIER JR, Lewis DA
    GABA and schizophrenia: Where we stand and where we need to go.
    Schizophr Res. 2017 Feb 5. pii: S0920-9964(17)30066.
    PubMed     Text format    


  17. BERNARDO M, Bioque M, Cabrera B, Lobo A, et al
    Modelling gene-environment interaction in first episodes of psychosis.
    Schizophr Res. 2017 Feb 5. pii: S0920-9964(17)30068.
    PubMed     Text format     Abstract available


  18. SHARMA A, Vogel M, Weisbrod M, Roesch-Ely D, et al
    Pronounced inhibition-related hypofrontal dysfunction in early-onset schizophrenia as indexed by NoGo-P300 amplitude.
    Schizophr Res. 2017 Feb 4. pii: S0920-9964(17)30074.
    PubMed     Text format    


  19. LUNSFORD-AVERY JR, Goncalves BD, Brietzke E, Bressan RA, et al
    Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up.
    Schizophr Res. 2017 Feb 4. pii: S0920-9964(17)30065.
    PubMed     Text format     Abstract available


  20. ALUSTIZA I, Radua J, Pla M, Martin R, et al
    Meta-analysis of functional magnetic resonance imaging studies of timing and cognitive control in schizophrenia and bipolar disorder: Evidence of a primary time deficit.
    Schizophr Res. 2017 Feb 3. pii: S0920-9964(17)30052.
    PubMed     Text format     Abstract available


  21. BUCHY L, Barbato M, Makowski C, Bray S, et al
    Mapping structural covariance networks of facial emotion recognition in early psychosis: A pilot study.
    Schizophr Res. 2017 Feb 3. pii: S0920-9964(17)30062.
    PubMed     Text format     Abstract available


    January 2017
  22. BARR MS, Rajji TK, Zomorrodi R, Radhu N, et al
    Impaired theta-gamma coupling during working memory performance in schizophrenia.
    Schizophr Res. 2017 Jan 29. pii: S0920-9964(17)30057.
    PubMed     Text format     Abstract available


  23. GREENLAND-WHITE SE, Ragland JD, Niendam TA, Ferrer E, et al
    Episodic memory functions in first episode psychosis and clinical high risk individuals.
    Schizophr Res. 2017 Jan 28. pii: S0920-9964(17)30048.
    PubMed     Text format     Abstract available


  24. ALONSO-SOLIS A, Vives-Gilabert Y, Portella MJ, Rabella M, et al
    Altered amplitude of low frequency fluctuations in schizophrenia patients with persistent auditory verbal hallucinations.
    Schizophr Res. 2017 Jan 28. pii: S0920-9964(17)30055.
    PubMed     Text format     Abstract available


  25. HENGARTNER MP, Heekeren K, Dvorsky D, Walitza S, et al
    Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Schizophr Res. 2017 Jan 27. pii: S0920-9964(17)30053.
    PubMed     Text format     Abstract available


  26. JOSEPH J, Kremen WS, Franz CE, Glatt SJ, et al
    Predictors of current functioning and functional decline in schizophrenia.
    Schizophr Res. 2017 Jan 27. pii: S0920-9964(17)30051.
    PubMed     Text format     Abstract available


  27. ZENG L, Kang C, Yuan J, Zhang Y, et al
    CYP2D6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia.
    Schizophr Res. 2017 Jan 26. pii: S0920-9964(17)30043.
    PubMed     Text format    


  28. FILATOVA S, Koivumaa-Honkanen H, Hirvonen N, Freeman A, et al
    Early motor developmental milestones and schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2017 Jan 25. pii: S0920-9964(17)30042.
    PubMed     Text format     Abstract available


  29. HARBER L, Takeuchi H, Borlido C, Hamidian R, et al
    Factors associated with drug attitude in patients with schizophrenia spectrum disorders.
    Schizophr Res. 2017 Jan 25. pii: S0920-9964(17)30046.
    PubMed     Text format    


  30. CHANG X, Collin G, Xi Y, Cui L, et al
    Resting-state functional connectivity in medication-naive schizophrenia patients with and without auditory verbal hallucinations: A preliminary report.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30037.
    PubMed     Text format     Abstract available


  31. KESHAVAN MS, Sudarshan M
    Deep dreaming, aberrant salience and psychosis: Connecting the dots by artificial neural networks.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30029.
    PubMed     Text format     Abstract available


  32. EMSLEY R, Chiliza B, Asmal L, Kilian S, et al
    Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30047.
    PubMed     Text format     Abstract available


  33. SMESNY S, Milleit B, Schaefer MR, Hesse J, et al
    Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
    Schizophr Res. 2017 Jan 23. pii: S0920-9964(17)30039.
    PubMed     Text format     Abstract available


  34. VINCENT PD, Demers MF, Doyon-Kemp V, Duchesneau J, et al
    One year mirror-image study using paliperidone palmitate for relapse prevention of schizophrenia in four university hospitals in Canada.
    Schizophr Res. 2017 Jan 21. pii: S0920-9964(17)30026.
    PubMed     Text format     Abstract available


  35. FIKSINSKI AM, Breetvelt EJ, Duijff SN, Bassett AS, et al
    Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study.
    Schizophr Res. 2017 Jan 21. pii: S0920-9964(17)30044.
    PubMed     Text format     Abstract available


  36. KIM SW, Polari A, Melville F, Moller B, et al
    Are current labeling terms suitable for people who are at risk of psychosis?
    Schizophr Res. 2017 Jan 20. pii: S0920-9964(17)30040.
    PubMed     Text format     Abstract available


  37. PARK CH, Lee S, Kim T, Won WY, et al
    Different alterations in brain functional networks according to direct and indirect topological connections in patients with schizophrenia.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(17)30038.
    PubMed     Text format     Abstract available


  38. ANDRIANARISOA M, Boyer L, Godin O, Brunel L, et al
    Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(16)30596.
    PubMed     Text format     Abstract available


  39. LIN CH, Wang FC, Lin SC, Huang YH, et al
    A randomized, double-blind, comparison of the efficacy and safety of low-dose olanzapine plus low-dose trifluoperazine versus full-dose olanzapine in the acute treatment of schizophrenia.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(17)30004.
    PubMed     Text format     Abstract available


  40. D'ADDARIO C, Micale V, Di Bartolomeo M, Stark T, et al
    A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30031.
    PubMed     Text format     Abstract available


  41. KU HL, Wang JK, Lee HC, Lane TJ, et al
    Cerebral blood flow autoregulation is impaired in schizophrenia: A pilot study.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30024.
    PubMed     Text format     Abstract available


  42. BAI Z, Wang G, Cai S, Ding X, et al
    Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30001.
    PubMed     Text format     Abstract available


  43. WU CHOU AI, Wang YC, Lin CL, Kao CH, et al
    Female schizophrenia patients and risk of breast cancer: A population-based cohort study.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30028.
    PubMed     Text format     Abstract available


  44. PINTO JV, Passos IC, Gomes F, Reckziegel R, et al
    Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approach.
    Schizophr Res. 2017 Jan 16. pii: S0920-9964(17)30023.
    PubMed     Text format    


  45. ALI FT, Abd El-Azeem EM, Hamed MA, Ali MA, et al
    Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
    Schizophr Res. 2017 Jan 15. pii: S0920-9964(17)30027.
    PubMed     Text format     Abstract available


  46. BORDON N, O'Rourke S, Hutton P
    The feasibility and clinical benefits of improving facial affect recognition impairments in schizophrenia: Systematic review and meta-analysis.
    Schizophr Res. 2017 Jan 14. pii: S0920-9964(17)30025.
    PubMed     Text format     Abstract available


  47. GROT S, Legare VP, Lipp O, Soulieres I, et al
    Abnormal prefrontal and parietal activity linked to deficient active binding in working memory in schizophrenia.
    Schizophr Res. 2017 Jan 14. pii: S0920-9964(17)30030.
    PubMed     Text format     Abstract available


  48. LINDENMAYER JP, Fregenti S, Kang G, Ozog V, et al
    The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits.
    Schizophr Res. 2017 Jan 13. pii: S0920-9964(17)30008.
    PubMed     Text format     Abstract available


  49. NARLA ST, Lee YW, Benson CA, Sarder P, et al
    Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).
    Schizophr Res. 2017 Jan 13. pii: S0920-9964(16)30568.
    PubMed     Text format     Abstract available


  50. JARSKOG LF, Pedersen CA, Johnson JL, Hamer RM, et al
    A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
    Schizophr Res. 2017 Jan 13. pii: S0920-9964(17)30007.
    PubMed     Text format     Abstract available


  51. MARTINEZ G, Alexandre C, Mam-Lam-Fook C, Bendjemaa N, et al
    Phenotypic continuum between autism and schizophrenia: Evidence from the Movie for the Assessment of Social Cognition (MASC).
    Schizophr Res. 2017 Jan 11. pii: S0920-9964(17)30013.
    PubMed     Text format     Abstract available


  52. KUMAR V, Venkatasubramanian G
    Extended (alternate day) antipsychotic dosing and dopamine supersensitivity psychosis: A case report.
    Schizophr Res. 2017 Jan 11. pii: S0920-9964(17)30009.
    PubMed     Text format    


  53. BLANCHARD JJ, Bradshaw KR, Garcia CP, Nasrallah HA, et al
    Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
    Schizophr Res. 2017 Jan 11. pii: S0920-9964(17)30011.
    PubMed     Text format     Abstract available


  54. DONG D, Wang Y, Chang X, Jiang Y, et al
    Shared abnormality of white matter integrity in schizophrenia and bipolar disorder: A comparative voxel-based meta-analysis.
    Schizophr Res. 2017 Jan 9. pii: S0920-9964(17)30005.
    PubMed     Text format     Abstract available


  55. SHOVESTUL BJ, Glassman M, Rowland LM, McMahon RP, et al
    Pilot study examining the relationship of childhood trauma, perceived stress, and medication use to serum kynurenic acid and kynurenine levels in schizophrenia.
    Schizophr Res. 2017 Jan 9. pii: S0920-9964(16)30601.
    PubMed     Text format    


  56. HAHN B, Harvey AN, Gold JM, Ross TJ, et al
    Load-dependent hyperdeactivation of the default mode network in people with schizophrenia.
    Schizophr Res. 2017 Jan 7. pii: S0920-9964(17)30002.
    PubMed     Text format     Abstract available


  57. BALAN S, Yamada K, Iwayama Y, Hashimoto T, et al
    Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia.
    Schizophr Res. 2017 Jan 7. pii: S0920-9964(17)30003.
    PubMed     Text format     Abstract available


  58. BENOIT A, Bowie CR, Lepage M
    Is cognitive insight relevant to functional capacity in schizophrenia?
    Schizophr Res. 2017 Jan 6. pii: S0920-9964(16)30569.
    PubMed     Text format    


  59. CONUS P, Cotton SM, Francey SM, O'Donoghue B, et al
    Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
    Schizophr Res. 2017 Jan 5. pii: S0920-9964(16)30605.
    PubMed     Text format     Abstract available


  60. AGNEW-BLAIS J, Seidman LJ, Fitzmaurice GM, Smoller JW, et al
    The interplay of childhood behavior problems and IQ in the development of later schizophrenia and affective psychoses.
    Schizophr Res. 2017 Jan 3. pii: S0920-9964(16)30570.
    PubMed     Text format     Abstract available


  61. MELLOR-MARSA B, Caballero FF, Cabello M, Ayuso-Mateos JL, et al
    Disability multilevel modelling in first episodes of psychosis at 3-year follow-up.
    Schizophr Res. 2017 Jan 3. pii: S0920-9964(16)30588.
    PubMed     Text format     Abstract available


    December 2016
  62. LYSTAD JU, Falkum E, Haaland VO, Bull H, et al
    Cognitive remediation and occupational outcome in schizophrenia spectrum disorders: A 2year follow-up study.
    Schizophr Res. 2016 Dec 29. pii: S0920-9964(16)30594.
    PubMed     Text format     Abstract available


  63. TASIC L, Pontes JG, Carvalho MS, Cruz G, et al
    Metabolomics and lipidomics analyses by 1H nuclear magnetic resonance of schizophrenia patient serum reveal potential peripheral biomarkers for diagnosis.
    Schizophr Res. 2016 Dec 28. pii: S0920-9964(16)30599.
    PubMed     Text format     Abstract available


  64. MORANDI S, Golay P, Lambert M, Schimmelmann BG, et al
    Community Treatment Order: Identifying the need for more evidence based justification of its use in first episode psychosis patients.
    Schizophr Res. 2016 Dec 27. pii: S0920-9964(16)30597.
    PubMed     Text format     Abstract available


  65. KESHAVAN MS, DeLisi LE, Nasrallah HA
    Translational and spectrum aspects of Schizophrenia Research: The rationale for new journal's new subheading.
    Schizophr Res. 2016 Dec 27. pii: S0920-9964(16)30547.
    PubMed     Text format    


  66. YALINCETIN B, Bora E, Binbay T, Ulas H, et al
    Formal thought disorder in schizophrenia and bipolar disorder: A systematic review and meta-analysis.
    Schizophr Res. 2016 Dec 22. pii: S0920-9964(16)30589.
    PubMed     Text format     Abstract available


  67. ABE D, Arai M, Itokawa M
    Music-evoked emotions in schizophrenia.
    Schizophr Res. 2016 Dec 22. pii: S0920-9964(16)30587.
    PubMed     Text format     Abstract available


  68. BOPP MH, Zollner R, Jansen A, Dietsche B, et al
    White matter integrity and symptom dimensions of schizophrenia: A diffusion tensor imaging study.
    Schizophr Res. 2016 Dec 21. pii: S0920-9964(16)30556.
    PubMed     Text format     Abstract available


  69. GANELLA EP, Bartholomeusz CF, Seguin C, Whittle S, et al
    Functional brain networks in treatment-resistant schizophrenia.
    Schizophr Res. 2016 Dec 20. pii: S0920-9964(16)30566.
    PubMed     Text format     Abstract available


  70. KRAKOWSKI MI, Czobor P
    Proneness to aggression and its inhibition in schizophrenia: Interconnections between personality traits, cognitive function and emotional processing.
    Schizophr Res. 2016 Dec 19. pii: S0920-9964(16)30548.
    PubMed     Text format     Abstract available


  71. MILLMAN ZB, Weintraub MJ, Bentley E, DeVylder JE, et al
    Differential relations of locus of control to perceived social stress among help-seeking adolescents at low vs. high clinical risk of psychosis.
    Schizophr Res. 2016 Dec 17. pii: S0920-9964(16)30563.
    PubMed     Text format     Abstract available


  72. NEILSON E, Bois C, Gibson J, Duff B, et al
    Effects of environmental risks and polygenic loading for schizophrenia on cortical thickness.
    Schizophr Res. 2016 Dec 15. pii: S0920-9964(16)30567.
    PubMed     Text format     Abstract available


  73. BREITBORDE NJ, Maple AM, Bell EK, Dawson SC, et al
    Activity-regulated cytoskeleton-associated protein predicts response to cognitive remediation among individuals with first-episode psychosis.
    Schizophr Res. 2016 Dec 15. pii: S0920-9964(16)30564.
    PubMed     Text format    


  74. RAMANATHAN S, Mattiaccio LM, Coman IL, Botti JC, et al
    Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome.
    Schizophr Res. 2016 Dec 14. pii: S0920-9964(16)30551.
    PubMed     Text format     Abstract available


  75. CANCEL A, Comte M, Boutet C, Schneider FC, et al
    Childhood trauma and emotional processing circuits in schizophrenia: A functional connectivity study.
    Schizophr Res. 2016 Dec 13. pii: S0920-9964(16)30561.
    PubMed     Text format     Abstract available


  76. DESERNO L, Heinz A, Schlagenhauf F
    Computational approaches to schizophrenia: A perspective on negative symptoms.
    Schizophr Res. 2016 Dec 13. pii: S0920-9964(16)30448.
    PubMed     Text format     Abstract available


  77. BRATTON H, O'Rourke S, Tansey L, Hutton P, et al
    Social cognition and paranoia in forensic inpatients with schizophrenia: A cross-sectional study.
    Schizophr Res. 2016 Dec 12. pii: S0920-9964(16)30562.
    PubMed     Text format     Abstract available


  78. EVINS AE, Hoeppner SS, Schoenfeld DA, Hoeppner BB, et al
    Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder.
    Schizophr Res. 2016 Dec 9. pii: S0920-9964(16)30511.
    PubMed     Text format     Abstract available


  79. RAHMANZADEH R, Eftekhari S, Khodaei Ardakani MR, Rahmanzade R, et al
    Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial.
    Schizophr Res. 2016 Dec 9. pii: S0920-9964(16)30560.
    PubMed     Text format    


  80. MCCARTHY NS, Melton PE, Ward SV, Allan SM, et al
    Exome array analysis suggests an increased variant burden in families with schizophrenia.
    Schizophr Res. 2016 Dec 8. pii: S0920-9964(16)30565.
    PubMed     Text format     Abstract available


  81. SHIOZAWA P, Fasanella NA, Marinho C, Taiar I, et al
    Trigeminal nerve stimulation (TNS) for treating negative symptoms in schizophrenia: A case study.
    Schizophr Res. 2016 Dec 7. pii: S0920-9964(16)30528.
    PubMed     Text format    


  82. CURRIE A, Nelson B
    Can repetitive transcranial magnetic stimulation improve neurocognition in schizophrenia when combined with cognitive remediation?
    Schizophr Res. 2016 Dec 7. pii: S0920-9964(16)30509.
    PubMed     Text format    


  83. LAURSEN TM, Trabjerg BB, Mors O, Borglum AD, et al
    Association of the polygenic risk score for schizophrenia with mortality and suicidal behavior - A Danish population-based study.
    Schizophr Res. 2016 Dec 6. pii: S0920-9964(16)30559.
    PubMed     Text format     Abstract available


  84. ANTICEVIC A
    Understanding the role of thalamic circuits in schizophrenia neuropathology.
    Schizophr Res. 2016 Dec 6. pii: S0920-9964(16)30555.
    PubMed     Text format    


  85. HAHN LA, Mackinnon A, Foley DL, Morgan VA, et al
    The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosis.
    Schizophr Res. 2016 Dec 6. pii: S0920-9964(16)30557.
    PubMed     Text format     Abstract available


  86. MECHELLI A, Lin A, Wood S, McGorry P, et al
    Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.
    Schizophr Res. 2016 Dec 3. pii: S0920-9964(16)30558.
    PubMed     Text format     Abstract available


  87. RAGAN C, Patel K, Edson J, Zhang ZH, et al
    Small non-coding RNA expression from anterior cingulate cortex in schizophrenia shows sex specific regulation.
    Schizophr Res. 2016 Dec 1. pii: S0920-9964(16)30517.
    PubMed     Text format     Abstract available


  88. SENGUPTA SM, MacDonald K, Fathalli F, Yim A, et al
    Polygenic Risk Score associated with specific symptom dimensions in first-episode psychosis.
    Schizophr Res. 2016 Dec 1. pii: S0920-9964(16)30549.
    PubMed     Text format     Abstract available


    November 2016
  89. OSBORNE KJ, Bernard JA, Gupta T, Dean DJ, et al
    Beat gestures and postural control in youth at ultrahigh risk for psychosis.
    Schizophr Res. 2016 Nov 30. pii: S0920-9964(16)30521.
    PubMed     Text format     Abstract available


  90. GIANFRANCESCO O, Warburton A, Collier DA, Bubb VJ, et al
    Novel brain expressed RNA identified at the MIR137 schizophrenia-associated locus.
    Schizophr Res. 2016 Nov 29. pii: S0920-9964(16)30529.
    PubMed     Text format     Abstract available


  91. LIN J, Geng X, Lee EH, Chan SK, et al
    Yoga reduces the brain's amplitude of low-frequency fluctuations in patients with early psychosis results of a randomized controlled trial.
    Schizophr Res. 2016 Nov 29. pii: S0920-9964(16)30550.
    PubMed     Text format    


  92. MOTHERSILL O, Tangney N, Morris DW, McCarthy H, et al
    Further evidence of alerted default network connectivity and association with theory of mind ability in schizophrenia.
    Schizophr Res. 2016 Nov 29. pii: S0920-9964(16)30553.
    PubMed     Text format     Abstract available


  93. COTTER J, Lin A, Drake RJ, Thompson A, et al
    Long-term employment among people at ultra-high risk for psychosis.
    Schizophr Res. 2016 Nov 27. pii: S0920-9964(16)30526.
    PubMed     Text format     Abstract available


  94. GUMLEY A, White R, Briggs A, Ford I, et al
    A parallel group randomised open blinded evaluation of Acceptance and Commitment Therapy for depression after psychosis: Pilot trial outcomes (ADAPT).
    Schizophr Res. 2016 Nov 25. pii: S0920-9964(16)30519.
    PubMed     Text format     Abstract available


  95. WANG C, Zhang Y
    Schizophrenia in mid-adulthood after prenatal exposure to the Chinese Famine of 1959-1961.
    Schizophr Res. 2016 Nov 25. pii: S0920-9964(16)30523.
    PubMed     Text format     Abstract available


  96. LEE JS, Kim CY, Joo YH, Newell D, et al
    Corrigendum to "Increased diffusivity in gray matter in recent onset schizophrenia is associated with clinical symptoms and social cognition" [Schizophr. Res. 176 (2-3) (Oct 2016) 144-150].
    Schizophr Res. 2016 Nov 25. pii: S0920-9964(16)30494.
    PubMed     Text format    


  97. BAYLISS JK, Bodarya K, Carson CM, Miller BJ, et al
    Recurrent urinary tract infections in children and adolescents with acute psychosis.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30522.
    PubMed     Text format    


  98. COUGHLIN JM, Hayes LN, Tanaka T, Xiao M, et al
    Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30492.
    PubMed     Text format     Abstract available


  99. O'KEEFFE J, Conway R, McGuire B
    A systematic review examining factors predicting favourable outcome in cognitive behavioural interventions for psychosis.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30514.
    PubMed     Text format     Abstract available


  100. CHANG H, Li L, Li M, Xiao X, et al
    Rare and common variants at 16p11.2 are associated with schizophrenia.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30524.
    PubMed     Text format     Abstract available


  101. ASMAL L, du Plessis S, Vink M, Fouche JP, et al
    Insight and white matter fractional anisotropy in first-episode schizophrenia.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30498.
    PubMed     Text format     Abstract available


  102. COUNOTTE J, Pot-Kolder R, van Roon AM, Hoskam O, et al
    High psychosis liability is associated with altered autonomic balance during exposure to Virtual Reality social stressors.
    Schizophr Res. 2016 Nov 22. pii: S0920-9964(16)30518.
    PubMed     Text format     Abstract available


  103. BORA E, Pantelis C
    Challenges facing the identification of distinctive cognitive and neurobiological features of schizophrenia and bipolar disorder and the need for a data-driven approach: Response to Dr. Martino.
    Schizophr Res. 2016 Nov 22. pii: S0920-9964(16)30516.
    PubMed     Text format    


  104. CHO H, Gonzalez R, Lavaysse LM, Pence S, et al
    Do people with schizophrenia experience more negative emotion and less positive emotion in their daily lives? A meta-analysis of experience sampling studies.
    Schizophr Res. 2016 Nov 21. pii: S0920-9964(16)30510.
    PubMed     Text format     Abstract available


  105. MARTINO DJ, Samame C, Strejilevich SA
    Social cognition in schizophrenia and bipolar disorder: Just quantitative differences..?
    Schizophr Res. 2016 Nov 21. pii: S0920-9964(16)30515.
    PubMed     Text format    


  106. WANG SB, Wang YY, Ungvari GS, Ng CH, et al
    The MacArthur Competence Assessment Tools for assessing decision-making capacity in schizophrenia: A meta-analysis.
    Schizophr Res. 2016 Nov 18. pii: S0920-9964(16)30512.
    PubMed     Text format     Abstract available


  107. CARNEY R, Bradshaw T, Firth J, Cotter J, et al
    Lifestyle factors may be linked to symptoms of metabolic syndrome in people at risk for psychosis.
    Schizophr Res. 2016 Nov 16. pii: S0920-9964(16)30506.
    PubMed     Text format    


  108. LIZANO PL, Yao JK, Tandon N, Mothi SS, et al
    Association of sFlt-1 and worsening psychopathology in relatives at high risk for psychosis: A longitudinal study.
    Schizophr Res. 2016 Nov 15. pii: S0920-9964(16)30508.
    PubMed     Text format     Abstract available


  109. KOYANAGI A, Oh H, Haro JM, Hirayama F, et al
    Child death and maternal psychosis-like experiences in 44 low- and middle-income countries: The role of depression.
    Schizophr Res. 2016 Nov 15. pii: S0920-9964(16)30505.
    PubMed     Text format     Abstract available


  110. FUJII T, Hattori K, Miyakawa T, Ohashi Y, et al
    Metabolic profile alterations in the postmortem brains of patients with schizophrenia using capillary electrophoresis-mass spectrometry.
    Schizophr Res. 2016 Nov 15. pii: S0920-9964(16)30504.
    PubMed     Text format     Abstract available


  111. SELTEN JP, Termorshuizen F
    The serological evidence for maternal influenza as risk factor for psychosis in offspring is insufficient: critical review and meta-analysis.
    Schizophr Res. 2016 Nov 14. pii: S0920-9964(16)30499.
    PubMed     Text format     Abstract available


  112. AKKUS F, Treyer V, Ametamey SM, Johayem A, et al
    Metabotropic glutamate receptor 5 neuroimaging in schizophrenia.
    Schizophr Res. 2016 Nov 12. pii: S0920-9964(16)30501.
    PubMed     Text format     Abstract available


  113. DE LA SERNA E, Sugranyes G, Sanchez-Gistau V, Rodriguez-Toscano E, et al
    Neuropsychological characteristics of child and adolescent offspring of patients with schizophrenia or bipolar disorder.
    Schizophr Res. 2016 Nov 12. pii: S0920-9964(16)30500.
    PubMed     Text format     Abstract available


  114. CARSON CM, Phillip N, Miller BJ
    Urinary tract infections in children and adolescents with acute psychosis.
    Schizophr Res. 2016 Nov 10. pii: S0920-9964(16)30497.
    PubMed     Text format     Abstract available


  115. KRKOVIC K, Moritz S, Lincoln TM
    Neurocognitive deficits or stress overload: Why do individuals with schizophrenia show poor performance in neurocognitive tests?
    Schizophr Res. 2016 Nov 9. pii: S0920-9964(16)30495.
    PubMed     Text format     Abstract available


  116. BROWN AS, Gyllenberg D, Hinkka-Yli-Salomaki S, Sourander A, et al
    Altered growth trajectory of head circumference during infancy and schizophrenia in a National Birth Cohort.
    Schizophr Res. 2016 Nov 4. pii: S0920-9964(16)30476.
    PubMed     Text format     Abstract available


    October 2016
  117. BEN-SHACHAR D
    Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target.
    Schizophr Res. 2016 Oct 29. pii: S0920-9964(16)30466.
    PubMed     Text format     Abstract available


  118. PADMANABHAN JL, Shah JL, Tandon N, Keshavan MS, et al
    The "polyenviromic risk score": Aggregating environmental risk factors predicts conversion to psychosis in familial high-risk subjects.
    Schizophr Res. 2016 Oct 29. pii: S0920-9964(16)30458.
    PubMed     Text format     Abstract available


  119. RAN MS, Wong YI, Yang SY, Ho PS, et al
    Marriage and outcomes of people with schizophrenia in rural China: 14-year follow-up study.
    Schizophr Res. 2016 Oct 28. pii: S0920-9964(16)30478.
    PubMed     Text format     Abstract available


  120. DUNAYEVICH E, Buchanan RW, Chen CY, Yang J, et al
    Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia.
    Schizophr Res. 2016 Oct 24. pii: S0920-9964(16)30471.
    PubMed     Text format     Abstract available


  121. MURRAY JD, Anticevic A
    Toward understanding thalamocortical dysfunction in schizophrenia through computational models of neural circuit dynamics.
    Schizophr Res. 2016 Oct 23. pii: S0920-9964(16)30465.
    PubMed     Text format     Abstract available


  122. KUNUTSOR SK, Laukkanen JA
    Serum gamma-glutamyltransferase is associated with future risk of psychosis - A prospective cohort study.
    Schizophr Res. 2016 Oct 21. pii: S0920-9964(16)30469.
    PubMed     Text format    


  123. HUI L, Han M, Yin GZ, Zhang Y, et al
    Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
    Schizophr Res. 2016 Oct 21. pii: S0920-9964(16)30472.
    PubMed     Text format     Abstract available


  124. IVANOVA SA, Osmanova DZ, Boiko AS, Pozhidaev IV, et al
    Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.
    Schizophr Res. 2016 Oct 21. pii: S0920-9964(16)30473.
    PubMed     Text format     Abstract available


  125. MUELLER TM, Yates SD, Haroutunian V, Meador-Woodruff JH, et al
    Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia.
    Schizophr Res. 2016 Oct 20. pii: S0920-9964(16)30468.
    PubMed     Text format     Abstract available


  126. KOTLICKA-ANTCZAK M, Pawelczyk A, Karbownik MS, Pawelczyk T, et al
    Deficits in the identification of pleasant odors predict the transition of an at-risk mental state to psychosis.
    Schizophr Res. 2016 Oct 17. pii: S0920-9964(16)30463.
    PubMed     Text format     Abstract available


  127. BULGARI V, Iozzino L, Ferrari C, Picchioni M, et al
    Clinical and neuropsychological features of violence in schizophrenia: A prospective cohort study.
    Schizophr Res. 2016 Oct 17. pii: S0920-9964(16)30460.
    PubMed     Text format     Abstract available


  128. KIM JH, Kim JH, Son YD, Joo YH, et al
    Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [11C]DASB and [18F]FDG.
    Schizophr Res. 2016 Oct 16. pii: S0920-9964(16)30464.
    PubMed     Text format     Abstract available


  129. CORDES J, Bechdolf A, Engelke C, Kahl KG, et al
    Prevalence of metabolic syndrome in female and male patients at risk of psychosis.
    Schizophr Res. 2016 Oct 14. pii: S0920-9964(16)30394.
    PubMed     Text format     Abstract available


  130. HARING L, Mottus R, Kajalaid K, Koch K, et al
    The course of cognitive functioning after first-episode of psychosis: A six month follow-up study.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30461.
    PubMed     Text format     Abstract available


  131. TULLY S, Wells A, Pyle M, Hudson J, et al
    Measuring common responses to psychosis: Assessing the psychometric properties of a new measure.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30459.
    PubMed     Text format     Abstract available


  132. RIDGEWELL C, Blackford JU, McHugo M, Heckers S, et al
    Personality traits predicting quality of life and overall functioning in schizophrenia.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30451.
    PubMed     Text format     Abstract available


  133. STEVENSON RA, Park S, Cochran C, McIntosh LG, et al
    The associations between multisensory temporal processing and symptoms of schizophrenia.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30444.
    PubMed     Text format     Abstract available


  134. GREENHALGH AM, Gonzalez-Blanco L, Garcia-Rizo C, Fernandez-Egea E, et al
    Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naive patients with nonaffective psychosis.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30435.
    PubMed     Text format     Abstract available


  135. DONDE C, Luck D, Grot S, Leitman DI, et al
    Tone-matching ability in patients with schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2016 Oct 11. pii: S0920-9964(16)30453.
    PubMed     Text format     Abstract available


  136. STARC M, Murray JD, Santamauro N, Savic A, et al
    Schizophrenia is associated with a pattern of spatial working memory deficits consistent with cortical disinhibition.
    Schizophr Res. 2016 Oct 10. pii: S0920-9964(16)30455.
    PubMed     Text format     Abstract available


  137. WINTON-BROWN TT, Elanjithara T, Power P, Coentre R, et al
    Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis.
    Schizophr Res. 2016 Oct 10. pii: S0920-9964(16)30437.
    PubMed     Text format     Abstract available


  138. SANCHEZ-TORRES AM, Elosua MR, Lorente-Omenaca R, Moreno-Izco L, et al
    Lifetime psychopathological dimensions, cognitive impairment and functional outcome in psychosis.
    Schizophr Res. 2016 Oct 9. pii: S0920-9964(16)30447.
    PubMed     Text format     Abstract available


  139. LANGE C, Deutschenbaur L, Borgwardt S, Lang UE, et al
    Experimentally induced psychosocial stress in schizophrenia spectrum disorders: A systematic review.
    Schizophr Res. 2016 Oct 9. pii: S0920-9964(16)30452.
    PubMed     Text format     Abstract available


  140. BROSEY EA, Woodward ND
    Neuroanatomical correlates of perceptual aberrations in psychosis.
    Schizophr Res. 2016 Oct 8. pii: S0920-9964(16)30450.
    PubMed     Text format     Abstract available


  141. ZHAI D, Lang Y, Dong G, Liu Y, et al
    QTc interval lengthening in first-episode schizophrenia (FES) patients in the earliest stages of antipsychotic treatment.
    Schizophr Res. 2016 Oct 7. pii: S0920-9964(16)30449.
    PubMed     Text format     Abstract available


  142. KUANG C, Buchy L, Barbato M, Makowski C, et al
    A pilot study of cognitive insight and structural covariance in first-episode psychosis.
    Schizophr Res. 2016 Oct 6. pii: S0920-9964(16)30443.
    PubMed     Text format     Abstract available


  143. TARGUM SD, Risinger R, Du Y, Pendergrass JC, et al
    Effect of patient age on treatment response in a study of the acute exacerbation of psychosis in schizophrenia.
    Schizophr Res. 2016 Oct 1. pii: S0920-9964(16)30442.
    PubMed     Text format     Abstract available


    September 2016
  144. FALKENBERG I, Valli I, Raffin M, Broome MR, et al
    Pattern of activation during delayed matching to sample task predicts functional outcome in people at ultra high risk for psychosis.
    Schizophr Res. 2016 Sep 29. pii: S0920-9964(16)30431.
    PubMed     Text format     Abstract available


  145. CORNACCHIO D, Pinkham AE, Penn DL, Harvey PD, et al
    Self-assessment of social cognitive ability in individuals with schizophrenia: Appraising task difficulty and allocation of effort.
    Schizophr Res. 2016 Sep 29. pii: S0920-9964(16)30441.
    PubMed     Text format     Abstract available


  146. RAUTIO N, Miettunen J, Jaaskelainen E, Nordstrom T, et al
    Do adverse perinatal events predict mortality in schizophrenia during midlife?
    Schizophr Res. 2016 Sep 27. pii: S0920-9964(16)30439.
    PubMed     Text format     Abstract available


  147. SELLERS R, Varese F, Wells A, Morrison AP, et al
    A meta-analysis of metacognitive beliefs as implicated in the self-regulatory executive function model in clinical psychosis.
    Schizophr Res. 2016 Sep 23. pii: S0920-9964(16)30440.
    PubMed     Text format     Abstract available


  148. ROSENHECK R, Mueser KT, Sint K, Lin H, et al
    Supported employment and education in comprehensive, integrated care for first episode psychosis: Effects on work, school, and disability income.
    Schizophr Res. 2016 Sep 22. pii: S0920-9964(16)30432.
    PubMed     Text format     Abstract available


  149. HAHN LA, Mackinnon A, Dr DL, Winthrop VA, et al
    The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis.
    Schizophr Res. 2016 Sep 22. pii: S0920-9964(16)30436.
    PubMed     Text format     Abstract available


  150. MASSEY SH, Stern D, Alden EC, Petersen JE, et al
    Cortical thickness of neural substrates supporting cognitive empathy in individuals with schizophrenia.
    Schizophr Res. 2016 Sep 21. pii: S0920-9964(16)30433.
    PubMed     Text format     Abstract available


  151. NOEL JP, Cascio CJ, Wallace MT, Park S, et al
    The spatial self in schizophrenia and autism spectrum disorder.
    Schizophr Res. 2016 Sep 17. pii: S0920-9964(16)30429.
    PubMed     Text format     Abstract available


  152. MOLINS C, Roldan A, Corripio I, Isohanni M, et al
    Response to antipsychotic drugs in treatment-resistant schizophrenia: Conclusions based on systematic review.
    Schizophr Res. 2016 Sep 17. pii: S0920-9964(16)30424.
    PubMed     Text format    


  153. HONG S, Lee EE, Martin AS, Soontornniyomkij B, et al
    Abnormalities in chemokine levels in schizophrenia and their clinical correlates.
    Schizophr Res. 2016 Sep 17. pii: S0920-9964(16)30427.
    PubMed     Text format     Abstract available


  154. RICHARD EA, Khlestova E, Nanu R, Lisman JE, et al
    Potential synergistic action of 19 schizophrenia risk genes in the thalamus.
    Schizophr Res. 2016 Sep 16. pii: S0920-9964(16)30390.
    PubMed     Text format     Abstract available


  155. ROCHE E, Lyne J, O'Donoghue B, Segurado R, et al
    The prognostic value of formal thought disorder following first episode psychosis.
    Schizophr Res. 2016 Sep 14. pii: S0920-9964(16)30425.
    PubMed     Text format     Abstract available


  156. CALDANI S, Bucci MP, Lamy JC, Seassau M, et al
    Saccadic eye movements as markers of schizophrenia spectrum: Exploration in at-risk mental states.
    Schizophr Res. 2016 Sep 14. pii: S0920-9964(16)30385.
    PubMed     Text format     Abstract available


  157. CHEN J, Calhoun VD, Pearlson GD, Perrone-Bizzozero NI, et al
    Independent component analysis of SNPs reflects polygenic risk scores for schizophrenia.
    Schizophr Res. 2016 Sep 13. pii: S0920-9964(16)30393.
    PubMed     Text format     Abstract available


  158. SAMALIN L, de Chazeron I, Blanc O, Brunel L, et al
    Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.
    Schizophr Res. 2016 Sep 13. pii: S0920-9964(16)30419.
    PubMed     Text format     Abstract available


  159. LANDIN-ROMERO R, McKenna PJ, Romaguera A, Alvarez-Moya E, et al
    Examining the continuum of psychosis: Frequency and characteristics of psychotic-like symptoms in relatives and non-relatives of patients with schizophrenia.
    Schizophr Res. 2016 Sep 12. pii: S0920-9964(16)30330.
    PubMed     Text format     Abstract available


  160. DUSI N, Bellani M, Perlini C, Squarcina L, et al
    Progressive disability and prefrontal shrinkage in schizophrenia patients with poor outcome: A 3-year longitudinal study.
    Schizophr Res. 2016 Sep 10. pii: S0920-9964(16)30395.
    PubMed     Text format     Abstract available


  161. FUJINO J, Hirose K, Tei S, Kawada R, et al
    Ambiguity aversion in schizophrenia: An fMRI study of decision-making under risk and ambiguity.
    Schizophr Res. 2016 Sep 9. pii: S0920-9964(16)30388.
    PubMed     Text format     Abstract available


  162. DUNCAN MJ, Arbour-Nicitopoulos K, Subramanieapillai M, Remington G, et al
    Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing physical activity among individuals with schizophrenia.
    Schizophr Res. 2016 Sep 9. pii: S0920-9964(16)30392.
    PubMed     Text format     Abstract available


  163. RAKHSHAN P, Sorensen H, DeVylder J, Mittal V, et al
    Childhood pegboard task predicts adult-onset psychosis-spectrum disorder among a genetic high-risk sample.
    Schizophr Res. 2016 Sep 9. pii: S0920-9964(16)30367.
    PubMed     Text format     Abstract available


  164. POISSON A, Schluth Bolard C, Martin B, Babinet MN, et al
    16q12.2q21: A new susceptibility locus for schizophrenia?
    Schizophr Res. 2016 Sep 8. pii: S0920-9964(16)30389.
    PubMed     Text format    


  165. SANCHEZ-TORRES AM, Elosua MR, Lorente-Omenaca R, Moreno-Izco L, et al
    The Cognitive Assessment Interview: A comparative study in first episode and chronic patients with psychosis.
    Schizophr Res. 2016 Sep 8. pii: S0920-9964(16)30378.
    PubMed     Text format     Abstract available


  166. PEARSALL R, Gareze J, Park J, Walker A, et al
    Routine data linkage to identify and monitor diabetes in clozapine-treated patients with schizophrenia.
    Schizophr Res. 2016 Sep 7. pii: S0920-9964(16)30375.
    PubMed     Text format    


  167. CAQUEO-URIZAR A, Fond G, Urzua A, Boyer L, et al
    Violent behavior and aggression in schizophrenia: Prevalence and risk factors. A multicentric study from three Latin-America countries.
    Schizophr Res. 2016 Sep 7. pii: S0920-9964(16)30387.
    PubMed     Text format     Abstract available


  168. ZHAI D, Cui T, Xu Y, Feng Y, et al
    Cardiometabolic risk in first-episode schizophrenia (FES) patients with the earliest stages of both illness and antipsychotic treatment.
    Schizophr Res. 2016 Sep 7. pii: S0920-9964(16)30383.
    PubMed     Text format     Abstract available


  169. SCHIMANSKI ID, Mouat KL, Billinghurst BL, Linscott RJ, et al
    Preliminary evidence that schizophrenia liability at age 15 predicts suicidal ideation two years later.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30380.
    PubMed     Text format     Abstract available


  170. BASLOW MH
    Is the tri-cellular N-acetylaspartylglutamate (NAAG) cycle related to the etiology of schizophrenia?
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30391.
    PubMed     Text format    


  171. ZAROGIANNI E, Storkey AJ, Johnstone EC, Owens DG, et al
    Improved individualized prediction of schizophrenia in subjects at familial high risk, based on neuroanatomical data, schizotypal and neurocognitive features.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30377.
    PubMed     Text format     Abstract available


  172. RAZAFIMANDIMBY A, Herve PY, Marzloff V, Brazo P, et al
    Functional deficit of the medial prefrontal cortex during emotional sentence attribution in schizophrenia.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30386.
    PubMed     Text format     Abstract available


  173. COBIA DJ, Smith MJ, Salinas I, Ng C, et al
    Progressive deterioration of thalamic nuclei relates to cortical network decline in schizophrenia.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30353.
    PubMed     Text format     Abstract available


  174. BRIDGMAN AC, Barr MS, Goodman MS, Zomorrodi R, et al
    Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30382.
    PubMed     Text format     Abstract available


  175. MISIAK B, Wisniewski J, Fleszar MG, Frydecka D, et al
    Alterations in l-arginine metabolism in first-episode schizophrenia patients: Further evidence for early metabolic dysregulation.
    Schizophr Res. 2016 Sep 5. pii: S0920-9964(16)30381.
    PubMed     Text format    


    August 2016
  176. MORITZ S, Balzan RP, Bohn F, Veckenstedt R, et al
    Subjective versus objective cognition: Evidence for poor metacognitive monitoring in schizophrenia.
    Schizophr Res. 2016 Aug 31. pii: S0920-9964(16)30371.
    PubMed     Text format     Abstract available


  177. CARNEY R, Yung AR, Amminger GP, Bradshaw T, et al
    Substance use in youth at risk for psychosis.
    Schizophr Res. 2016 Aug 30. pii: S0920-9964(16)30376.
    PubMed     Text format     Abstract available


  178. KIMURA H, Wang C, Ishizuka K, Xing J, et al
    Identification of a rare variant in CHD8 that contributes to schizophrenia and autism spectrum disorder susceptibility.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30373.
    PubMed     Text format    


  179. DANDASH O, Pantelis C, Fornito A
    Dopamine, fronto-striato-thalamic circuits and risk for psychosis.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30370.
    PubMed     Text format     Abstract available


  180. VERMA D, Srivastava MK, Singh SK, Bhatia T, et al
    Lifetime suicide intent, executive function and insight in schizophrenia and schizoaffective disorders.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30359.
    PubMed     Text format    


  181. SERE L, Cardona D, Flichtentrei D, Lopez P, et al
    Schizophrenia: Is it time to rename it? The opinions of Latin American psychiatrists.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30369.
    PubMed     Text format    


  182. REDDY LF, Llerena K, Kern RS
    Predictors of employment in schizophrenia: The importance of intrinsic and extrinsic motivation.
    Schizophr Res. 2016 Aug 25. pii: S0920-9964(16)30356.
    PubMed     Text format     Abstract available


  183. BESTEHER B, Wagner G, Koch K, Schachtzabel C, et al
    Pronounced prefronto-temporal cortical thinning in schizophrenia: Neuroanatomical correlate of suicidal behavior?
    Schizophr Res. 2016 Aug 24. pii: S0920-9964(16)30360.
    PubMed     Text format     Abstract available


  184. DORPH-PETERSEN KA, Lewis DA
    Postmortem structural studies of the thalamus in schizophrenia.
    Schizophr Res. 2016 Aug 23. pii: S0920-9964(16)30357.
    PubMed     Text format     Abstract available


  185. CICERO DC, Klaunig MJ, Trask CL, Neis AM, et al
    Anomalous Self-Experiences and positive symptoms are independently associated with emotion processing deficits in schizophrenia.
    Schizophr Res. 2016 Aug 22. pii: S0920-9964(16)30368.
    PubMed     Text format     Abstract available


  186. LEE JS, Kim CY, Joo YH, Newell D, et al
    Increased diffusivity in gray matter in recent onset schizophrenia is associated with clinical symptoms and social cognition.
    Schizophr Res. 2016 Aug 20. pii: S0920-9964(16)30361.
    PubMed     Text format     Abstract available


  187. LIEMBURG EJ, Bruins J, van Beveren N, Islam MA, et al
    Cannabis and a lower BMI in psychosis: What is the role of AKT1?
    Schizophr Res. 2016 Aug 20. pii: S0920-9964(16)30364.
    PubMed     Text format     Abstract available


  188. STAIN HJ, Bucci S, Baker AL, Carr V, et al
    A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: The detection and evaluation of psychological therapy (DEPTh) trial.
    Schizophr Res. 2016 Aug 20. pii: S0920-9964(16)30358.
    PubMed     Text format     Abstract available


  189. ADAMCZYK P, Daren A, Sulecka A, Bladzinski P, et al
    Do better communication skills promote sheltered employment in schizophrenia?
    Schizophr Res. 2016 Aug 18. pii: S0920-9964(16)30365.
    PubMed     Text format     Abstract available


  190. JEON DW, Shim JC, Kong BG, Moon JJ, et al
    Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trial.
    Schizophr Res. 2016 Aug 16. pii: S0920-9964(16)30366.
    PubMed     Text format     Abstract available


  191. YOSHIDA K, Suzuki T, Imasaka Y, Kubo KI, et al
    Corrigendum to "resilience in schizophrenia: A comparative study between a remote island and an urban area in Japan" [Schizophr. Res. Volume 171, Issues 1-3, March 2016, Pages 92-96].
    Schizophr Res. 2016 Aug 15. pii: S0920-9964(16)30363.
    PubMed     Text format    


  192. BROWN JS JR
    Cases of remission of psychosis following resection of pheochromocytoma or paraganglioma.
    Schizophr Res. 2016 Aug 14. pii: S0920-9964(16)30362.
    PubMed     Text format     Abstract available


  193. GIRALDO-CHICA M, Woodward ND
    Review of thalamocortical resting-state fMRI studies in schizophrenia.
    Schizophr Res. 2016 Aug 13. pii: S0920-9964(16)30355.
    PubMed     Text format     Abstract available


  194. MAMAH D, Musau A, Mutiso VN, Owoso A, et al
    Characterizing psychosis risk traits in Africa: A longitudinal study of Kenyan adolescents.
    Schizophr Res. 2016 Aug 10. pii: S0920-9964(16)30354.
    PubMed     Text format     Abstract available


  195. GOMES JS, Akiba H, Dias AM, Soares A, et al
    Trigeminal Nerve Stimulation for olfactory hallucinations in schizophrenia: case study.
    Schizophr Res. 2016 Aug 8. pii: S0920-9964(16)30352.
    PubMed     Text format    


  196. YOUNG A, Wimmer RD
    Implications for the thalamic reticular nucleus in impaired attention and sleep in schizophrenia.
    Schizophr Res. 2016 Aug 7. pii: S0920-9964(16)30327.
    PubMed     Text format     Abstract available


  197. HAIGH SM, Coffman BA, Murphy TK, Butera CD, et al
    Abnormal auditory pattern perception in schizophrenia.
    Schizophr Res. 2016 Aug 5. pii: S0920-9964(16)30323.
    PubMed     Text format     Abstract available


  198. WILLI TS, Lang DJ, Honer WG, Smith GN, et al
    Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users.
    Schizophr Res. 2016 Aug 4. pii: S0920-9964(16)30351.
    PubMed     Text format     Abstract available


  199. DRUCAROFF LJ, Costanzo EY, Castro MN, Ortiz-Villafane M, et al
    Hemispheric specialization of mood processing is abnormal in patients with schizophrenia.
    Schizophr Res. 2016 Aug 1. pii: S0920-9964(16)30350.
    PubMed     Text format    


    July 2016
  200. LI X, Thermenos HW, Wu Z, Momura Y, et al
    Abnormal interactions of verbal- and spatial-memory networks in young people at familial high-risk for schizophrenia.
    Schizophr Res. 2016 Jul 29. pii: S0920-9964(16)30348.
    PubMed     Text format     Abstract available


  201. PETRWINKLER, Mlada K, Krupchanka D, Agius M, et al
    Corrigendum to "Long-term hospitalizations for schizophrenia in the Czech Republic 1998-2012" (Schizophr. Res. vol. 175, issues 1-3, August 2016, pages 180-185).
    Schizophr Res. 2016 Jul 28. pii: S0920-9964(16)30347.
    PubMed     Text format    


  202. HALLFORD P, Clair DS, Halley L, Mustard C, et al
    A study of type-1 diabetes associated autoantibodies in schizophrenia.
    Schizophr Res. 2016 Jul 26. pii: S0920-9964(16)30346.
    PubMed     Text format     Abstract available


  203. CHUANG YA, Hu TM, Chen CH, Hsu SH, et al
    Rare mutations and hypermethylation of the ARC gene associated with schizophrenia.
    Schizophr Res. 2016 Jul 24. pii: S0920-9964(16)30345.
    PubMed     Text format     Abstract available


  204. SANTELMANN H, Franklin J, Busshoff J, Baethge C, et al
    Interrater reliability of schizoaffective disorder compared with schizophrenia, bipolar disorder, and unipolar depression - A systematic review and meta-analysis.
    Schizophr Res. 2016 Jul 22. pii: S0920-9964(16)30328.
    PubMed     Text format     Abstract available


  205. KITTIPEERACHON M, Chaichan W
    Intramuscular olanzapine versus intramuscular aripiprazole for the treatment of agitation in patients with schizophrenia: A pragmatic double-blind randomized trial.
    Schizophr Res. 2016 Jul 22. pii: S0920-9964(16)30333.
    PubMed     Text format     Abstract available


  206. VAN DEN BERG DP, van der Vleugel BM, de Bont PA, Staring AB, et al
    Predicting trauma-focused treatment outcome in psychosis.
    Schizophr Res. 2016 Jul 20. pii: S0920-9964(16)30332.
    PubMed     Text format     Abstract available


  207. PERGOLA G, Trizio S, Di Carlo P, Taurisano P, et al
    Grey matter volume patterns in thalamic nuclei are associated with familial risk for schizophrenia.
    Schizophr Res. 2016 Jul 20. pii: S0920-9964(16)30321.
    PubMed     Text format     Abstract available


  208. SADOWSKA-BARTOSZ I, Galiniak S, Bartosz G, Zuberek M, et al
    Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia.
    Schizophr Res. 2016 Jul 20. pii: S0920-9964(16)30326.
    PubMed     Text format     Abstract available


  209. HESS JL, Tylee DS, Barve R, de Jong S, et al
    Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia.
    Schizophr Res. 2016 Jul 19. pii: S0920-9964(16)30322.
    PubMed     Text format     Abstract available


  210. BORNHEIMER LA
    Moderating effects of positive symptoms of psychosis in suicidal ideation among adults diagnosed with schizophrenia.
    Schizophr Res. 2016 Jul 19. pii: S0920-9964(16)30325.
    PubMed     Text format     Abstract available


  211. MCCLEERY A, Lee J, Fiske AP, Ghermezi L, et al
    Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing.
    Schizophr Res. 2016 Jul 18. pii: S0920-9964(16)30324.
    PubMed     Text format     Abstract available


  212. DURGAM S, Earley W, Li R, Li D, et al
    Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial.
    Schizophr Res. 2016 Jul 14. pii: S0920-9964(16)30312.
    PubMed     Text format     Abstract available


  213. SHIM M, Hwang HJ, Kim DW, Lee SH, et al
    Machine-learning-based diagnosis of schizophrenia using combined sensor-level and source-level EEG features.
    Schizophr Res. 2016 Jul 14. pii: S0920-9964(16)30227.
    PubMed     Text format     Abstract available


  214. WOOD L, Burke E, Byrne R, Enache G, et al
    Semi-structured Interview Measure of Stigma (SIMS) in psychosis: Assessment of psychometric properties.
    Schizophr Res. 2016 Jul 13. pii: S0920-9964(16)30275.
    PubMed     Text format     Abstract available


  215. ZENI-GRAIFF M, Rizzo LB, Mansur RB, Maurya PK, et al
    Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis.
    Schizophr Res. 2016 Jul 13. pii: S0920-9964(16)30313.
    PubMed     Text format     Abstract available


  216. CELLA M, Edwards C, Wykes T
    A question of time: A study of time use in people with schizophrenia.
    Schizophr Res. 2016 Jul 12. pii: S0920-9964(16)30315.
    PubMed     Text format     Abstract available


  217. LEVINE SZ, Levav I, Pugachova I, Yoffe R, et al
    Transgenerational effects of genocide exposure on the risk and course of schizophrenia: A population-based study.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30286.
    PubMed     Text format     Abstract available


  218. GUAN F, Zhang T, Li L, Fu D, et al
    Two-stage replication of previous genome-wide association studies of AS3MT-CNNM2-NT5C2 gene cluster region in a large schizophrenia case-control sample from Han Chinese population.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30320.
    PubMed     Text format     Abstract available


  219. WOMER FY, Tang Y, Harms MP, Bai C, et al
    Sexual dimorphism of the cerebellar vermis in schizophrenia.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30310.
    PubMed     Text format     Abstract available


  220. DOLLFUS S, Lyne J
    Negative symptoms: History of the concept and their position in diagnosis of schizophrenia.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30291.
    PubMed     Text format    


  221. MORRA LF, Strauss GP
    Severity of hypertension predicts the generalized neurocognitive deficit in schizophrenia.
    Schizophr Res. 2016 Jul 7. pii: S0920-9964(16)30317.
    PubMed     Text format     Abstract available


  222. SAWA A, Sedlak TW
    Oxidative stress and inflammation in schizophrenia.
    Schizophr Res. 2016 Jul 6. pii: S0920-9964(16)30281.
    PubMed     Text format    


  223. ZHANG B, Deng L, Wu H, Lu X, et al
    Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and beta-CrossLaps.
    Schizophr Res. 2016 Jul 2. pii: S0920-9964(16)30316.
    PubMed     Text format     Abstract available


    June 2016
  224. GURURAJAN A, Malone DT
    Does cannabidiol have a role in the treatment of schizophrenia?
    Schizophr Res. 2016 Jun 30. pii: S0920-9964(16)30289.
    PubMed     Text format     Abstract available


  225. FALKAI P, Schmitt A
    News from the graveyard: Neuropathological research on schizophrenia is alive and productive.
    Schizophr Res. 2016 Jun 29. pii: S0920-9964(16)30311.
    PubMed     Text format    


  226. GOGHARI VM, Harrow M
    Twenty year multi-follow-up of different types of hallucinations in schizophrenia, schizoaffective disorder, bipolar disorder, and depression.
    Schizophr Res. 2016 Jun 24. pii: S0920-9964(16)30309.
    PubMed     Text format     Abstract available


  227. GRENT-'T-JONG T, Rivolta D, Sauer A, Grube M, et al
    MEG-measured visually induced gamma-band oscillations in chronic schizophrenia: Evidence for impaired generation of rhythmic activity in ventral stream regions.
    Schizophr Res. 2016 Jun 24. pii: S0920-9964(16)30270.
    PubMed     Text format     Abstract available


  228. LIM A, Hoek HW, Deen ML, Blom JD, et al
    Prevalence and classification of hallucinations in multiple sensory modalities in schizophrenia spectrum disorders.
    Schizophr Res. 2016 Jun 24. pii: S0920-9964(16)30277.
    PubMed     Text format     Abstract available


  229. MICHAEL J, Park S
    Anomalous bodily experiences and perceived social isolation in schizophrenia: An extension of the Social Deafferentation Hypothesis.
    Schizophr Res. 2016 Jun 23. pii: S0920-9964(16)30280.
    PubMed     Text format     Abstract available


  230. ON ZX, Cotton S, Farhall J, Killackey E, et al
    Relationship between duration of untreated psychosis and neurocognition and social cognition in first-episode psychosis.
    Schizophr Res. 2016 Jun 23. pii: S0920-9964(16)30285.
    PubMed     Text format     Abstract available


  231. KIRKBRIDE JB, Perez J, Jones PB
    Neighbourhood communalities and ultra-high risk psychosis: An emergent literature.
    Schizophr Res. 2016 Jun 22. pii: S0920-9964(16)30288.
    PubMed     Text format    


  232. KEANE BP, Silverstein SM, Wang Y, Roche MW, et al
    Seeing more clearly through psychosis: Depth inversion illusions are normal in bipolar disorder but reduced in schizophrenia.
    Schizophr Res. 2016 Jun 22. pii: S0920-9964(16)30282.
    PubMed     Text format     Abstract available


  233. KUHL JO, Laursen TM, Thorup A, Nordentoft M, et al
    The incidence of schizophrenia and schizophrenia spectrum disorders in Denmark in the period 2000-2012. A register-based study.
    Schizophr Res. 2016 Jun 21. pii: S0920-9964(16)30290.
    PubMed     Text format     Abstract available


  234. SANTOS CM, Peres FF, Diana MC, Justi V, et al
    Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model.
    Schizophr Res. 2016 Jun 21. pii: S0920-9964(16)30273.
    PubMed     Text format     Abstract available


  235. EDWARDS AC, Bacanu SA, Bigdeli TB, Moscati A, et al
    Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study.
    Schizophr Res. 2016 Jun 20. pii: S0920-9964(16)30283.
    PubMed     Text format     Abstract available


  236. COX DA, Gottschalk MG, Wesseling H, Ernst A, et al
    Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.
    Schizophr Res. 2016 Jun 19. pii: S0920-9964(16)30279.
    PubMed     Text format     Abstract available


  237. SAVILL M, Orfanos S, Reininghaus U, Wykes T, et al
    The relationship between experiential deficits of negative symptoms and subjective quality of life in schizophrenia.
    Schizophr Res. 2016 Jun 18. pii: S0920-9964(16)30284.
    PubMed     Text format     Abstract available


  238. SALLMEN M, Suvisaari J, Lindbohm ML, Malaspina D, et al
    Paternal occupational lead exposure and offspring risks for schizophrenia.
    Schizophr Res. 2016 Jun 15. pii: S0920-9964(16)30271.
    PubMed     Text format     Abstract available


  239. LEE EE, Eyler LT, Wolkowitz OM, Martin AS, et al
    Elevated plasma F2-isoprostane levels in schizophrenia.
    Schizophr Res. 2016 Jun 15. pii: S0920-9964(16)30278.
    PubMed     Text format     Abstract available


  240. BORA E, Veznedaroglu B, Vahip S
    Theory of mind and executive functions in schizophrenia and bipolar disorder: A cross-diagnostic latent class analysis for identification of neuropsychological subtypes.
    Schizophr Res. 2016 Jun 14. pii: S0920-9964(16)30274.
    PubMed     Text format     Abstract available


  241. RAFFARD S, Bortolon C, Khoramshahi M, Salesse RN, et al
    Humanoid robots versus humans: How is emotional valence of facial expressions recognized by individuals with schizophrenia? An exploratory study.
    Schizophr Res. 2016 Jun 9. pii: S0920-9964(16)30268.
    PubMed     Text format     Abstract available


  242. IWASHIRO N, Koike S, Satomura Y, Suga M, et al
    Letter to the editor; A corrigendum with respect to our research article entitled "Association between impaired brain activity and volume at the sub-region of Broca's area in ultra-high risk and first-episode schizophrenia: A multi-modal neuroimaging
    Schizophr Res. 2016 Jun 6. pii: S0920-9964(16)30267.
    PubMed     Text format    


  243. FERRARELLI F, Tononi G
    Reduced sleep spindle activity point to a TRN-MD thalamus-PFC circuit dysfunction in schizophrenia.
    Schizophr Res. 2016 Jun 3. pii: S0920-9964(16)30247.
    PubMed     Text format     Abstract available


  244. ALVARADO-ALANIS P, Leon-Ortiz P, Reyes-Madrigal F, Favila R, et al
    Corrigendum to "abnormal white matter integrity in antipsychotic-naive first-episode psychosis patients assessed by a DTI principal component analysis" [Schizophr. Res. 162 (1-3) (march 2015) 14-21].
    Schizophr Res. 2016 Jun 2. pii: S0920-9964(16)30249.
    PubMed     Text format    


  245. RANDALL JR, Chateau D, Smith M, Taylor C, et al
    An early intervention for psychosis and its effect on criminal accusations and suicidal behaviour using a matched-cohort design.
    Schizophr Res. 2016 Jun 1. pii: S0920-9964(16)30244.
    PubMed     Text format     Abstract available


  246. DICKERSON F, Adamos MB, Katsafanas E, Khushalani S, et al
    The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.
    Schizophr Res. 2016 Jun 1. pii: S0920-9964(16)30246.
    PubMed     Text format     Abstract available


    May 2016
  247. STUBBS B, Firth J, Berry A, Schuch FB, et al
    How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression.
    Schizophr Res. 2016 May 31. pii: S0920-9964(16)30241.
    PubMed     Text format     Abstract available


  248. PERALTA V, Cuesta MJ
    Characteristics and clinical correlates of dimensions of delusional experience in schizophrenia and delusional disorder.
    Schizophr Res. 2016 May 31. pii: S0920-9964(16)30248.
    PubMed     Text format    


  249. TAKEUCHI H, Fervaha G, Lee J, Remington G, et al
    What symptom domains are associated with patient distress in schizophrenia?
    Schizophr Res. 2016 May 31. pii: S0920-9964(16)30245.
    PubMed     Text format    


  250. WOOD L, Byrne R, Varese F, Morrison AP, et al
    Psychosocial interventions for internalised stigma in people with a schizophrenia-spectrum diagnosis: A systematic narrative synthesis and meta-analysis.
    Schizophr Res. 2016 May 30. pii: S0920-9964(16)30219.
    PubMed     Text format     Abstract available


  251. DE DEYNE S, Elvevag B, Hui CL, Poon VW, et al
    Rich semantic networks applied to schizophrenia: A new framework.
    Schizophr Res. 2016 May 28. pii: S0920-9964(16)30240.
    PubMed     Text format    


  252. REDDY LF, Green MF, Wynn JK, Rinck M, et al
    Approaching anger in schizophrenia: What an implicit task tells you that self-report does not.
    Schizophr Res. 2016 May 27. pii: S0920-9964(16)30242.
    PubMed     Text format     Abstract available


  253. MCFADDEN WC, Jaffe AE, Ye T, Paltan-Ortiz JD, et al
    Assessment of genetic risk for distribution of total interstitial white matter neurons in dorsolateral prefrontal cortex: role in schizophrenia.
    Schizophr Res. 2016 May 27. pii: S0920-9964(16)30156.
    PubMed     Text format    


  254. FU YY, Zhang T, Xiu MH, Tang W, et al
    Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia.
    Schizophr Res. 2016 May 26. pii: S0920-9964(16)30232.
    PubMed     Text format     Abstract available


  255. PINACHO R, Villalmanzo N, Meana JJ, Ferrer I, et al
    Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia.
    Schizophr Res. 2016 May 25. pii: S0920-9964(16)30220.
    PubMed     Text format     Abstract available


  256. HASSAN AN, Stuart EA, De Luca V
    Childhood maltreatment increases the risk of suicide attempt in schizophrenia.
    Schizophr Res. 2016 May 25. pii: S0920-9964(16)30236.
    PubMed     Text format     Abstract available


  257. HESLIN M, Lappin JM, Donoghue K, Lomas B, et al
    Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients.
    Schizophr Res. 2016 May 25. pii: S0920-9964(16)30198.
    PubMed     Text format     Abstract available


  258. FOTI D, Perlman G, Hajcak G, Mohanty A, et al
    Impaired error processing in late-phase psychosis: Four-year stability and relationships with negative symptoms.
    Schizophr Res. 2016 May 24. pii: S0920-9964(16)30230.
    PubMed     Text format     Abstract available


  259. SEOW LS, Ong C, Mahesh MV, Sagayadevan V, et al
    A systematic review on comorbid post-traumatic stress disorder in schizophrenia.
    Schizophr Res. 2016 May 23. pii: S0920-9964(16)30225.
    PubMed     Text format     Abstract available


  260. SAPRA M, Lawson D, Iranmanesh A, Varma A, et al
    Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics.
    Schizophr Res. 2016 May 19. pii: S0920-9964(16)30221.
    PubMed     Text format     Abstract available


  261. GALDERISI S, Rossi A, Rocca P, Bertolino A, et al
    Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives.
    Schizophr Res. 2016 May 18. pii: S0920-9964(16)30189.
    PubMed     Text format     Abstract available


  262. CELIK C, Balikci A, Ozdemir B, Oznur T, et al
    BDNF and other biological markers are associated with schizophrenia onset and positive symptoms: A different approach.
    Schizophr Res. 2016 May 18. pii: S0920-9964(16)30226.
    PubMed     Text format    


  263. BAUDIN G, Godin O, Lajnef M, Aouizerate B, et al
    Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia.
    Schizophr Res. 2016 May 18. pii: S0920-9964(16)30190.
    PubMed     Text format     Abstract available


  264. MORITZ S, Ludtke T, Westermann S, Hermeneit J, et al
    Dysfunctional coping with stress in psychosis. An investigation with the Maladaptive and Adaptive Coping Styles (MAX) questionnaire.
    Schizophr Res. 2016 May 17. pii: S0920-9964(16)30174.
    PubMed     Text format     Abstract available


  265. MORITZ S, Schroder J, Klein JP, Lincoln TM, et al
    Effects of online intervention for depression on mood and positive symptoms in schizophrenia.
    Schizophr Res. 2016 May 17. pii: S0920-9964(16)30182.
    PubMed     Text format     Abstract available


  266. HOU CL, Xiang YT, Wang ZL, Everall I, et al
    Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.
    Schizophr Res. 2016 May 16. pii: S0920-9964(16)30183.
    PubMed     Text format     Abstract available


  267. ROMINGER C, Bleier A, Fitz W, Marksteiner J, et al
    Auditory top-down control and affective theory of mind in schizophrenia with and without hallucinations.
    Schizophr Res. 2016 May 16. pii: S0920-9964(16)30228.
    PubMed     Text format     Abstract available


  268. KANE JM, Skuban A, Hobart M, Ouyang J, et al
    Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia.
    Schizophr Res. 2016 May 14. pii: S0920-9964(16)30162.
    PubMed     Text format     Abstract available


  269. MIZUNO Y, Hofer A, Suzuki T, Frajo-Apor B, et al
    Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: A cross-sectional study.
    Schizophr Res. 2016 May 13. pii: S0920-9964(16)30196.
    PubMed     Text format     Abstract available


  270. GALDERISI S, Farden A, Kaiser S
    Dissecting negative symptoms of schizophrenia: History, assessment, pathophysiological mechanisms and treatment.
    Schizophr Res. 2016 May 13. pii: S0920-9964(16)30195.
    PubMed     Text format    


  271. DEAN B, Copolov D, Scarr E
    Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain Bank.
    Schizophr Res. 2016 May 12. pii: S0920-9964(16)30186.
    PubMed     Text format     Abstract available


  272. BARKER V, Bois C, Neilson E, Johnstone EC, et al
    Childhood adversity and hippocampal and amygdala volumes in a population at familial high risk of schizophrenia.
    Schizophr Res. 2016 May 11. pii: S0920-9964(16)30177.
    PubMed     Text format     Abstract available


  273. CERETTA AP, Schaffer LF, de Freitas CM, Reinheimer JB, et al
    Gabapentin prevents behavioral changes on the amphetamine-induced animal model of schizophrenia.
    Schizophr Res. 2016 May 11. pii: S0920-9964(16)30193.
    PubMed     Text format    


  274. ALBACETE A, Bosque C, Custal N, Crespo JM, et al
    Emotional intelligence in non-psychotic first-degree relatives of people with schizophrenia.
    Schizophr Res. 2016 May 10. pii: S0920-9964(16)30188.
    PubMed     Text format     Abstract available


  275. AOKI A, Aoki Y, Goulden R, Kasai K, et al
    Change in newspaper coverage of schizophrenia in Japan over 20-year period.
    Schizophr Res. 2016 May 10. pii: S0920-9964(16)30175.
    PubMed     Text format     Abstract available


  276. NELSON B, Yuen HP, Lin A, Wood SJ, et al
    Further examination of the reducing transition rate in ultra high risk for psychosis samples: The possible role of earlier intervention.
    Schizophr Res. 2016 May 9. pii: S0920-9964(16)30191.
    PubMed     Text format     Abstract available


  277. DEIGHTON S, Buchy L, Cadenhead KS, Cannon TD, et al
    Traumatic brain injury in individuals at clinical high risk for psychosis.
    Schizophr Res. 2016 May 7. pii: S0920-9964(16)30192.
    PubMed     Text format     Abstract available


  278. KINDLER J, Schultze-Lutter F, Michel C, Martz-Irngartinger A, et al
    Abnormal involuntary movements are linked to psychosis-risk in children and adolescents: Results of a population-based study.
    Schizophr Res. 2016 May 7. pii: S0920-9964(16)30181.
    PubMed     Text format     Abstract available


  279. PACCALET T, Gilbert E, Berthelot N, Marquet P, et al
    Liability indicators aggregate many years before transition to illness in offspring descending from kindreds affected by schizophrenia or bipolar disorder.
    Schizophr Res. 2016 May 6. pii: S0920-9964(16)30187.
    PubMed     Text format    


  280. BERNIER D, Bartha R, McAllindon D, Hanstock CC, et al
    Illness versus substance use effects on the frontal white matter in early phase schizophrenia: A 4Tesla H-MRS study.
    Schizophr Res. 2016 May 5. pii: S0920-9964(16)30172.
    PubMed     Text format     Abstract available


  281. KOYANAGI A, Stickley A, Haro JM
    Subclinical psychosis and pain in an English national sample: The role of common mental disorders.
    Schizophr Res. 2016 May 5. pii: S0920-9964(16)30180.
    PubMed     Text format     Abstract available


  282. PINACHO R, Vila E, Prades R, Tarrago T, et al
    The glial phosphorylase of glycogen isoform is reduced in the dorsolateral prefrontal cortex in chronic schizophrenia.
    Schizophr Res. 2016 May 4. pii: S0920-9964(16)30169.
    PubMed     Text format     Abstract available


  283. MILLER BJ, Goldsmith DR, Paletta N, Wong J, et al
    Parental type 2 diabetes in patients with non-affective psychosis.
    Schizophr Res. 2016 May 4. pii: S0920-9964(16)30184.
    PubMed     Text format     Abstract available


  284. MALLA A, Mustafa S, Rho A, Abadi S, et al
    Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.
    Schizophr Res. 2016 May 3. pii: S0920-9964(16)30185.
    PubMed     Text format     Abstract available


  285. CORRELL CU, Skuban A, Hobart M, Ouyang J, et al
    Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies.
    Schizophr Res. 2016 May 3. pii: S0920-9964(16)30161.
    PubMed     Text format     Abstract available


  286. VIKHREVA OV, Rakhmanova VI, Orlovskaya DD, Uranova NA, et al
    Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: A post-mortem morphometric study.
    Schizophr Res. 2016 May 2. pii: S0920-9964(16)30173.
    PubMed     Text format     Abstract available


  287. PAKSARIAN D, Merikangas KR, Calkins ME, Gur RE, et al
    Erratum to "Racial-ethnic disparities in empirically-derived subtypes of subclinical psychosis among a U.S. sample of youths" [Schizophr. Res. 170 (2016) 205-210].
    Schizophr Res. 2016;173.
    PubMed     Text format    


    April 2016
  288. DUNN W, Rassovsky Y, Wynn JK, Wu AD, et al
    Modulation of neurophysiological auditory processing measures by bilateral transcranial direct current stimulation in schizophrenia.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30171.
    PubMed     Text format     Abstract available


  289. MILLARD SP, Shofer J, Braff D, Calkins M, et al
    Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30160.
    PubMed     Text format     Abstract available


  290. JOHANSSON AS, Owe-Larsson B, Hetta J, Lundkvist GB, et al
    Altered circadian clock gene expression in patients with schizophrenia.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30178.
    PubMed     Text format     Abstract available


  291. GEE B, Hodgekins J, Fowler D, Marshall M, et al
    The course of negative symptom in first episode psychosis and the relationship with social recovery.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30166.
    PubMed     Text format     Abstract available


  292. CZEPIELEWSKI LS, Massuda R, Panizzutti B, da Rosa ED, et al
    Telomere length in subjects with schizophrenia, their unaffected siblings and healthy controls: Evidence of accelerated aging.
    Schizophr Res. 2016 Apr 27. pii: S0920-9964(16)30135.
    PubMed     Text format     Abstract available


  293. STEPHAN-OTTO C, Siddi S, Cuevas Esteban J, Senior C, et al
    Neural activity during object perception in schizophrenia patients is associated with illness duration and affective symptoms.
    Schizophr Res. 2016 Apr 26. pii: S0920-9964(16)30170.
    PubMed     Text format     Abstract available


  294. GARCIA-BEA A, Walker MA, Hyde TM, Kleinman JE, et al
    Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study.
    Schizophr Res. 2016 Apr 26. pii: S0920-9964(16)30164.
    PubMed     Text format     Abstract available


  295. CASEY D, Brown L, Galwani R, Islam Z, et al
    Predictors of engagement in first-episode psychosis.
    Schizophr Res. 2016 Apr 25. pii: S0920-9964(16)30179.
    PubMed     Text format     Abstract available


  296. UHRIG S, Hirth N, Broccoli L, von Wilmsdorff M, et al
    Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: A post-mortem study.
    Schizophr Res. 2016 Apr 25. pii: S0920-9964(16)30168.
    PubMed     Text format     Abstract available


  297. BORA E, Pantelis C
    Social cognition in schizophrenia in comparison to bipolar disorder: A meta-analysis.
    Schizophr Res. 2016 Apr 22. pii: S0920-9964(16)30167.
    PubMed     Text format     Abstract available


  298. HUBER CG, Hochstrasser L, Meister K, Schimmelmann BG, et al
    Evidence for an agitated-aggressive syndrome in early-onset psychosis correlated with antisocial personality disorder, forensic history, and substance use disorder.
    Schizophr Res. 2016 Apr 22. pii: S0920-9964(16)30176.
    PubMed     Text format     Abstract available


  299. KLINE E, Millman ZB, Denenny D, Wilson C, et al
    Trauma and psychosis symptoms in a sample of help-seeking youth.
    Schizophr Res. 2016 Apr 20. pii: S0920-9964(16)30155.
    PubMed     Text format     Abstract available


  300. JOHN J, Bhatia T, Kukshal P, Chandna P, et al
    Association study of MiRSNPs with schizophrenia, tardive dyskinesia and cognition.
    Schizophr Res. 2016 Apr 19. pii: S0920-9964(16)30123.
    PubMed     Text format     Abstract available


  301. VERU F, Jordan G, Joober R, Malla A, et al
    Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms.
    Schizophr Res. 2016 Apr 18. pii: S0920-9964(16)30127.
    PubMed     Text format     Abstract available


  302. VOGEL T, Smieskova R, Schmidt A, Walter A, et al
    Increased superior frontal gyrus activation during working memory processing in psychosis: Significant relation to cumulative antipsychotic medication and to negative symptoms.
    Schizophr Res. 2016 Apr 18. pii: S0920-9964(16)30125.
    PubMed     Text format     Abstract available


  303. OHI K, Kikuchi M, Ikeda M, Yamamori H, et al
    Polygenetic components for schizophrenia, bipolar disorder and rheumatoid arthritis predict risk of schizophrenia.
    Schizophr Res. 2016 Apr 17. pii: S0920-9964(16)30158.
    PubMed     Text format    


  304. SAIA-CEREDA VM, Cassoli JS, Schmitt A, Falkai P, et al
    Differential proteome and phosphoproteome may impact cell signaling in the corpus callosum of schizophrenia patients.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30114.
    PubMed     Text format     Abstract available


  305. VAN HAREN NE, Kahn RS
    Progressive brain tissue loss in schizophrenia.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30115.
    PubMed     Text format    


  306. WINKLER P, Mlada K, Krupchanka D, Agius M, et al
    Long-term hospitalizations for schizophrenia in the Czech Republic 1998-2012.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30157.
    PubMed     Text format     Abstract available


  307. VITA A, Deste G, Barlati S, Grano A, et al
    Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia?
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30126.
    PubMed     Text format     Abstract available


  308. BONFILS KA, Lysaker PH, Minor KS, Salyers MP, et al
    Affective empathy in schizophrenia: a meta-analysis.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30129.
    PubMed     Text format     Abstract available


  309. WANG MY, Ho NF, Sum MY, Collinson SL, et al
    Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia.
    Schizophr Res. 2016 Apr 14. pii: S0920-9964(16)30134.
    PubMed     Text format     Abstract available


  310. MAVROGIORGOU P, Dunnweber M, Juckel G
    Obsessive compulsive symptoms (OCS) in patients with schizophrenia are rare.
    Schizophr Res. 2016 Apr 13. pii: S0920-9964(16)30132.
    PubMed     Text format    


  311. HAIGH SM, Gupta A, Barb SM, Glass SA, et al
    Differential sensory fMRI signatures in autism and schizophrenia: Analysis of amplitude and trial-to-trial variability.
    Schizophr Res. 2016 Apr 12. pii: S0920-9964(16)30128.
    PubMed     Text format     Abstract available


  312. BJORKQUIST OA, Olsen EK, Nelson BD, Herbener ES, et al
    Altered amygdala-prefrontal connectivity during emotion perception in schizophrenia.
    Schizophr Res. 2016 Apr 12. pii: S0920-9964(16)30136.
    PubMed     Text format     Abstract available


  313. WIMBERLEY T, Pedersen CB, MacCabe JH, Stovring H, et al
    Inverse association between urbanicity and treatment resistance in schizophrenia.
    Schizophr Res. 2016 Apr 8. pii: S0920-9964(16)30113.
    PubMed     Text format     Abstract available


  314. GONZALEZ-PENAS J, Amigo J, Santome L, Sobrino B, et al
    Targeted resequencing of regulatory regions at schizophrenia risk loci: Role of rare functional variants at chromatin repressive states.
    Schizophr Res. 2016 Apr 8. pii: S0920-9964(16)30121.
    PubMed     Text format     Abstract available


  315. ISITT JJ, Nadipelli VR, Kouassi A, Fava M, et al
    Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study.
    Schizophr Res. 2016 Apr 7. pii: S0920-9964(16)30105.
    PubMed     Text format     Abstract available


  316. OHI K, Shimada T, Nitta Y, Kihara H, et al
    Specific gene expression patterns of 108 schizophrenia-associated loci in cortex.
    Schizophr Res. 2016 Apr 6. pii: S0920-9964(16)30124.
    PubMed     Text format     Abstract available


  317. CHOU PH, Chu CS, Lin CH, Cheng C, et al
    Use of atypical antipsychotics and risks of cataract development in patients with schizophrenia: A population-based, nested case-control study.
    Schizophr Res. 2016 Apr 6. pii: S0920-9964(16)30120.
    PubMed     Text format     Abstract available


  318. GONZALEZ-BLANCO L, Greenhalgh AM, Garcia-Rizo C, Egea EF, et al
    Prolactin concentrations in antipsychotic-naive patients with schizophrenia and related disorders: A meta-analysis.
    Schizophr Res. 2016 Apr 5. pii: S0920-9964(16)30111.
    PubMed     Text format     Abstract available


  319. SHIN YS, Kim SY, Lee TY, Hur JW, et al
    Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
    Schizophr Res. 2016 Apr 5. pii: S0920-9964(16)30116.
    PubMed     Text format     Abstract available


  320. ONWUAMEZE OE, Titone D, Ho BC
    Transitive inference deficits in unaffected biological relatives of schizophrenia patients.
    Schizophr Res. 2016 Apr 2. pii: S0920-9964(16)30071.
    PubMed     Text format     Abstract available


  321. HUI CL, Poon VW, Ko WT, Miao HY, et al
    Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis.
    Schizophr Res. 2016 Apr 2. pii: S0920-9964(16)30118.
    PubMed     Text format     Abstract available


  322. BERGH S, Hjorthoj C, Sorensen HJ, Fagerlund B, et al
    Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10years after baseline: The OPUS study.
    Schizophr Res. 2016 Apr 2. pii: S0920-9964(16)30117.
    PubMed     Text format     Abstract available


  323. NIEMAN DH, Dragt S, van Duin ED, Denneman N, et al
    COMT ValMet genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.
    Schizophr Res. 2016 Apr 1. pii: S0920-9964(16)30108.
    PubMed     Text format     Abstract available


  324. GREENWOOD KE, Morris R, Smith V, Jones AM, et al
    Virtual shopping: A viable alternative to direct assessment of real life function?
    Schizophr Res. 2016;172.
    PubMed     Text format     Abstract available


  325. BLANCO-LOPEZ MJ, Cudeiro-Blanco J, Iglesias G, Gago A, et al
    A simple, repeated rTMS protocol effectively removes auditory verbal hallucinations in a single patient study.
    Schizophr Res. 2016;172.
    PubMed     Text format    


  326. STONE WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, et al
    Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.
    Schizophr Res. 2016;172.
    PubMed     Text format     Abstract available


  327. DE SOUSA P, Sellwood W, Spray A, Bentall RP, et al
    The affective reactivity of psychotic speech: The role of internal source monitoring in explaining increased thought disorder under emotional challenge.
    Schizophr Res. 2016;172.
    PubMed     Text format     Abstract available


    March 2016
  328. COFFMAN BA, Haigh SM, Murphy TK, Salisbury DF, et al
    Event-related potentials demonstrate deficits in acoustic segmentation in schizophrenia.
    Schizophr Res. 2016 Mar 28. pii: S0920-9964(16)30103.
    PubMed     Text format     Abstract available


  329. SHUKLA AA, Jha M, Birchfield T, Mukherjee S, et al
    COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
    Schizophr Res. 2016 Mar 24. pii: S0920-9964(16)30112.
    PubMed     Text format     Abstract available


  330. WRIGHT B, Peters E, Ettinger U, Kuipers E, et al
    Effects of environmental noise on cognitive (dys)functions in schizophrenia: A pilot within-subjects experimental study.
    Schizophr Res. 2016 Mar 23. pii: S0920-9964(16)30110.
    PubMed     Text format     Abstract available


  331. CHANG WC, Kwong VW, Chan GH, Jim OT, et al
    Prediction of functional remission in first-episode psychosis: 12-month follow-up of the randomized-controlled trial on extended early intervention in Hong Kong.
    Schizophr Res. 2016 Mar 23. pii: S0920-9964(16)30109.
    PubMed     Text format     Abstract available


  332. ANTONUCCI LA, Taurisano P, Fazio L, Gelao B, et al
    Association of familial risk for schizophrenia with thalamic and medial prefrontal functional connectivity during attentional control.
    Schizophr Res. 2016 Mar 21. pii: S0920-9964(16)30107.
    PubMed     Text format     Abstract available


  333. POTVIN S, Lungu O, Lipp O, Lalonde P, et al
    Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings.
    Schizophr Res. 2016 Mar 18. pii: S0920-9964(16)30104.
    PubMed     Text format     Abstract available


  334. OMER S, Finnegan M, Pringle DG, Kinsella A, et al
    Socioeconomic status at birth and risk for first episode psychosis in rural Ireland: Eliminating the features of urbanicity in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).
    Schizophr Res. 2016 Mar 17. pii: S0920-9964(16)30098.
    PubMed     Text format     Abstract available


  335. CUI LB, Liu K, Li C, Wang LX, et al
    Putamen-related regional and network functional deficits in first-episode schizophrenia with auditory verbal hallucinations.
    Schizophr Res. 2016 Mar 16. pii: S0920-9964(16)30093.
    PubMed     Text format     Abstract available


  336. WU CS, Cheng IC, Feng J, Chen CL, et al
    Comparison of treatment effectiveness and medical costs for different long-acting injectable antipsychotics in patients with schizophrenia in Taiwan: A nationwide population-based cohort study.
    Schizophr Res. 2016 Mar 14. pii: S0920-9964(16)30091.
    PubMed     Text format     Abstract available


  337. ARMSTRONG HF, Bartels MN, Paslavski O, Cain D, et al
    The impact of aerobic exercise training on cardiopulmonary functioning in individuals with schizophrenia.
    Schizophr Res. 2016 Mar 11. pii: S0920-9964(16)30102.
    PubMed     Text format    


  338. VOLK DW, Edelson JR, Lewis DA
    Altered expression of developmental regulators of parvalbumin and somatostatin neurons in the prefrontal cortex in schizophrenia.
    Schizophr Res. 2016 Mar 10. pii: S0920-9964(16)30094.
    PubMed     Text format     Abstract available


  339. RAUTIO N, Kakela J, Nordstrom T, Miettunen J, et al
    Prognosis of schizophrenia spectrum disorder may not be predetermined during early development - the Northern Finland Birth Cohort 1966.
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30092.
    PubMed     Text format     Abstract available


  340. KANAHARA N, Kimura H, Iyo M
    Reply to "concern over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia".
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30099.
    PubMed     Text format    


  341. BARAKAUSKAS VE, Moradian A, Barr AM, Beasley CL, et al
    Quantitative mass spectrometry reveals changes in SNAP-25 isoforms in schizophrenia.
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30095.
    PubMed     Text format     Abstract available


  342. NAEEM F, Johal R, McKenna C, Rathod S, et al
    Cognitive Behavior Therapy for psychosis based Guided Self-help (CBTp-GSH) delivered by frontline mental health professionals: Results of a feasibility study.
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30096.
    PubMed     Text format     Abstract available


  343. TARRICONE I, Boydell J, Kokona A, Triolo F, et al
    Risk of psychosis and internal migration: Results from the Bologna First Episode Psychosis study.
    Schizophr Res. 2016 Mar 8. pii: S0920-9964(16)30088.
    PubMed     Text format     Abstract available


  344. THERMENOS HW, Juelich RJ, DiChiara SR, Mesholam-Gately RI, et al
    Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis.
    Schizophr Res. 2016 Mar 7. pii: S0920-9964(16)30078.
    PubMed     Text format     Abstract available


  345. BERNSTEIN HG, Hildebrandt J, Dobrowolny H, Steiner J, et al
    Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula.
    Schizophr Res. 2016 Mar 3. pii: S0920-9964(16)30090.
    PubMed     Text format     Abstract available


  346. DEPP CA, Moore RC, Perivoliotis D, Holden JL, et al
    Social behavior, interaction appraisals, and suicidal ideation in schizophrenia: The dangers of being alone.
    Schizophr Res. 2016 Mar 2. pii: S0920-9964(16)30083.
    PubMed     Text format     Abstract available


  347. DAVIDSON CA, Johannesen JK, Fiszdon JM
    Role of learning potential in cognitive remediation: Construct and predictive validity.
    Schizophr Res. 2016;171.
    PubMed     Text format     Abstract available


    February 2016
  348. GARDSJORD ES, Romm KL, Friis S, Barder HE, et al
    Subjective quality of life in first-episode psychosis. A ten year follow-up study.
    Schizophr Res. 2016 Feb 29. pii: S0920-9964(16)30087.
    PubMed     Text format     Abstract available


  349. MALASPINA D, Kranz TM, Heguy A, Harroch S, et al
    Prefrontal neuronal integrity predicts symptoms and cognition in schizophrenia and is sensitive to genetic heterogeneity.
    Schizophr Res. 2016 Feb 26. pii: S0920-9964(16)30085.
    PubMed     Text format     Abstract available


  350. BRANDT AS, Unschuld PG, Pradhan S, Lim IA, et al
    Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A H MRS Study at 7Tesla.
    Schizophr Res. 2016 Feb 26. pii: S0920-9964(16)30073.
    PubMed     Text format     Abstract available


  351. MOE AM, Breitborde NJ, Shakeel MK, Gallagher CJ, et al
    Idea density in the life-stories of people with schizophrenia: Associations with narrative qualities and psychiatric symptoms.
    Schizophr Res. 2016 Feb 26. pii: S0920-9964(16)30072.
    PubMed     Text format     Abstract available


  352. SALGADO-PINEDA P, Landin-Romero R, Portillo F, Bosque C, et al
    Examining hippocampal function in schizophrenia using a virtual reality spatial navigation task.
    Schizophr Res. 2016 Feb 25. pii: S0920-9964(16)30089.
    PubMed     Text format     Abstract available


  353. FRAJO-APOR B, Pardeller S, Kemmler G, Welte AS, et al
    Emotional Intelligence deficits in schizophrenia: The impact of non-social cognition.
    Schizophr Res. 2016 Feb 25. pii: S0920-9964(16)30082.
    PubMed     Text format     Abstract available


  354. STEINER J, Brisch R, Schiltz K, Dobrowolny H, et al
    GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: A post-mortem study.
    Schizophr Res. 2016 Feb 24. pii: S0920-9964(16)30074.
    PubMed     Text format     Abstract available


  355. LITMAN RE, Smith MA, Doherty JJ, Cross A, et al
    AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.
    Schizophr Res. 2016 Feb 24. pii: S0920-9964(16)30057.
    PubMed     Text format     Abstract available


  356. LANDOLT K, Rossler W, Ajdacic-Gross V, Derks EM, et al
    Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST).
    Schizophr Res. 2016 Feb 24. pii: S0920-9964(16)30046.
    PubMed     Text format     Abstract available


  357. MOSKOW DM, Addington J, Bearden CE, Cadenhead KS, et al
    The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis.
    Schizophr Res. 2016 Feb 20. pii: S0920-9964(16)30058.
    PubMed     Text format     Abstract available


  358. BATTY RA, Francis A, Thomas N, Hopwood M, et al
    Predicting co-morbid traumatic brain injury and psychosis from neuropsychological profile.
    Schizophr Res. 2016 Feb 19. pii: S0920-9964(16)30076.
    PubMed     Text format    


  359. BUCHY L, Barbato M, MacMaster FP, Bray S, et al
    Cognitive insight is associated with cortical thickness in first-episode psychosis.
    Schizophr Res. 2016 Feb 18. pii: S0920-9964(16)30081.
    PubMed     Text format     Abstract available


  360. XIAO X, Li M
    Replication of Han Chinese GWAS loci for schizophrenia via meta-analysis of four independent samples.
    Schizophr Res. 2016 Feb 18. pii: S0920-9964(16)30075.
    PubMed     Text format     Abstract available


  361. ALLSWEDE DM, Buka SL, Yolken RH, Torrey EF, et al
    Elevated maternal cytokine levels at birth and risk for psychosis in adult offspring.
    Schizophr Res. 2016 Feb 17. pii: S0920-9964(16)30077.
    PubMed     Text format     Abstract available


  362. FORERO DA, Herteleer L, De Zutter S, Norrback KF, et al
    A network of synaptic genes associated with schizophrenia and bipolar disorder.
    Schizophr Res. 2016 Feb 15. pii: S0920-9964(16)30068.
    PubMed     Text format     Abstract available


  363. NIELSEN PR, Meyer U, Mortensen PB
    Individual and combined effects of maternal anemia and prenatal infection on risk for schizophrenia in offspring.
    Schizophr Res. 2016 Feb 15. pii: S0920-9964(16)30080.
    PubMed     Text format     Abstract available


  364. DAGANI J, Sisti D, Abelli M, Di Paolo L, et al
    Do we need oxytocin to treat schizophrenia? A randomized clinical trial.
    Schizophr Res. 2016 Feb 13. pii: S0920-9964(16)30067.
    PubMed     Text format     Abstract available


  365. DARRELL-BERRY H, Berry K, Bucci S
    The relationship between paranoia and aggression in psychosis: A systematic review.
    Schizophr Res. 2016 Feb 12. pii: S0920-9964(16)30065.
    PubMed     Text format     Abstract available


  366. LEE MR, Wehring HJ, McMahon RP, Liu F, et al
    Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.
    Schizophr Res. 2016 Feb 12. pii: S0920-9964(16)30070.
    PubMed     Text format     Abstract available


  367. OAKLEY C, Harris S, Fahy T, Murphy D, et al
    Childhood adversity and conduct disorder: A developmental pathway to violence in schizophrenia.
    Schizophr Res. 2016 Feb 12. pii: S0920-9964(16)30047.
    PubMed     Text format     Abstract available


  368. PIERRE JM, Gandal M, Son M
    Cannabis-induced psychosis associated with high potency "wax dabs".
    Schizophr Res. 2016 Feb 11. pii: S0920-9964(16)30056.
    PubMed     Text format     Abstract available


  369. KNOCHEL C, Reuter J, Reinke B, Stablein M, et al
    Cortical thinning in bipolar disorder and schizophrenia.
    Schizophr Res. 2016 Feb 11. pii: S0920-9964(16)30063.
    PubMed     Text format     Abstract available


  370. PINNER AL, Tucholski J, Haroutunian V, McCullumsmith RE, et al
    Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia.
    Schizophr Res. 2016 Feb 11. pii: S0920-9964(16)30055.
    PubMed     Text format     Abstract available


  371. ROMERO-FERREIRO MV, Aguado L, Rodriguez-Torresano J, Palomo T, et al
    Facial affect recognition in early and late-stage schizophrenia patients.
    Schizophr Res. 2016 Feb 10. pii: S0920-9964(16)30066.
    PubMed     Text format     Abstract available


  372. IWASHIRO N, Koike S, Satomura Y, Suga M, et al
    Association between impaired brain activity and volume at the sub-region of Broca's area in ultra-high risk and first-episode schizophrenia: A multi-modal neuroimaging study.
    Schizophr Res. 2016 Feb 9. pii: S0920-9964(16)30061.
    PubMed     Text format     Abstract available


  373. PERES FF, Diana MC, Suiama MA, Justi V, et al
    Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30060.
    PubMed     Text format    


  374. CAO B, Wang DF, Xu MY, Liu YQ, et al
    Vitamin B and the risk of schizophrenia: A meta-analysis.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30051.
    PubMed     Text format    


  375. KOCAZEYBEK B, Yuksel P
    A contribution to the Torrey et al.'s "cat ownership in childhood is a significant risk factor for later developing schizophrenia" study.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30052.
    PubMed     Text format    


  376. NIENOW TM, MacDonald AW 3rd, Lim KO
    TDCS produces incremental gain when combined with working memory training in patients with schizophrenia: A proof of concept pilot study.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30053.
    PubMed     Text format    


  377. VENTURA J, Subotnik KL, Ered A, Hellemann GS, et al
    Cognitive Assessment Interview (CAI): Validity as a co-primary measure of cognition across phases of schizophrenia.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30030.
    PubMed     Text format     Abstract available


  378. ZENG B, Ardekani BA, Tang Y, Zhang T, et al
    Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.
    Schizophr Res. 2016 Feb 3. pii: S0920-9964(16)30050.
    PubMed     Text format     Abstract available


  379. KIMHY D, Lauriola V, Bartels MN, Armstrong HF, et al
    Aerobic exercise for cognitive deficits in schizophrenia - The impact of frequency, duration, and fidelity with target training intensity.
    Schizophr Res. 2016 Feb 3. pii: S0920-9964(16)30054.
    PubMed     Text format    


  380. TARASENKO M, Perez VB, Pianka ST, Vinogradov S, et al
    Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophrenia.
    Schizophr Res. 2016 Feb 2. pii: S0920-9964(16)30017.
    PubMed     Text format     Abstract available


  381. GADELHA A, Coleman J, Breen G, Mazzoti DR, et al
    Genome-wide investigation of schizophrenia associated plasma Ndel1 enzyme activity.
    Schizophr Res. 2016 Feb 2. pii: S0920-9964(16)30043.
    PubMed     Text format     Abstract available


  382. XU Z, Muller M, Heekeren K, Theodoridou A, et al
    Pathways between stigma and suicidal ideation among people at risk of psychosis.
    Schizophr Res. 2016 Feb 1. pii: S0920-9964(16)30048.
    PubMed     Text format     Abstract available


  383. LODHI RJ, Masand S, Malik A, Shivakumar K, et al
    Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study.
    Schizophr Res. 2016;170.
    PubMed     Text format     Abstract available


    January 2016
  384. PU S, Nakagome K, Itakura M, Iwata M, et al
    The association between cognitive deficits and prefrontal hemodynamic responses during performance of working memory task in patients with schizophrenia.
    Schizophr Res. 2016 Jan 30. pii: S0920-9964(16)30045.
    PubMed     Text format     Abstract available


  385. LALANDE D, Theriault L, Kalinova E, Fortin A, et al
    The effect of exercise on sleep quality and psychological, physiological, and biological correlates in patients with schizophrenia: A pilot study.
    Schizophr Res. 2016 Jan 28. pii: S0920-9964(16)30041.
    PubMed     Text format    


  386. KNOCHEL C, Stablein M, Prvulovic D, Ghinea D, et al
    Shared and distinct gray matter abnormalities in schizophrenia, schizophrenia relatives and bipolar disorder in association with cognitive impairment.
    Schizophr Res. 2016 Jan 28. pii: S0920-9964(16)30025.
    PubMed     Text format     Abstract available


  387. KARPOUZIAN TM, Alden EC, Reilly JL, Smith MJ, et al
    High functioning individuals with schizophrenia have preserved social perception but not mentalizing abilities.
    Schizophr Res. 2016 Jan 27. pii: S0920-9964(16)30031.
    PubMed     Text format     Abstract available


  388. LALLY J, Tully J, Robertson D, Stubbs B, et al
    Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2016 Jan 27. pii: S0920-9964(16)30024.
    PubMed     Text format     Abstract available


  389. FULLARD JF, Halene TB, Giambartolomei C, Haroutunian V, et al
    Understanding the genetic liability to schizophrenia through the neuroepigenome.
    Schizophr Res. 2016 Jan 27. pii: S0920-9964(16)30039.
    PubMed     Text format     Abstract available


  390. BUCCI P, Mucci A, Piegari G, Nobile M, et al
    Characterization of premorbid functioning during childhood in patients with deficit vs. non-deficit schizophrenia and in their healthy siblings.
    Schizophr Res. 2016 Jan 26. pii: S0920-9964(16)30035.
    PubMed     Text format     Abstract available


  391. BI R, Tang J, Zhang W, Li X, et al
    Mitochondrial genome variations and functional characterization in Han Chinese families with schizophrenia.
    Schizophr Res. 2016 Jan 25. pii: S0920-9964(16)30011.
    PubMed     Text format     Abstract available


  392. HO RT, Fong TC, Wan AH, Au-Yeung FS, et al
    A randomized controlled trial on the psychophysiological effects of physical exercise and Tai-chi in patients with chronic schizophrenia.
    Schizophr Res. 2016 Jan 25. pii: S0920-9964(16)30038.
    PubMed     Text format     Abstract available


  393. BLIKSTED V, Ubukata S, Koelkebeck K
    Discriminating autism spectrum disorders from schizophrenia by investigation of mental state attribution on an on-line mentalizing task: A review and meta-analysis.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30028.
    PubMed     Text format     Abstract available


  394. VUKADINOVIC Z
    Elevated striatal dopamine and efference copy failure in schizophrenia.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30040.
    PubMed     Text format    


  395. CSUKLY G, Farkas K, Marosi C, Szabo A, et al
    Deficits in low beta desynchronization reflect impaired emotional processing in schizophrenia.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30029.
    PubMed     Text format     Abstract available


  396. BURTON CZ, Harvey PD, Patterson TL, Twamley EW, et al
    Neurocognitive insight and objective cognitive functioning in schizophrenia.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30022.
    PubMed     Text format     Abstract available


  397. SUGAI T, Suzuki Y, Yamazaki M, Shimoda K, et al
    Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey.
    Schizophr Res. 2016 Jan 22. pii: S0920-9964(16)30016.
    PubMed     Text format     Abstract available


  398. LENG CH, Chou MH, Lin SH, Yang YK, et al
    Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan.
    Schizophr Res. 2016 Jan 22. pii: S0920-9964(16)30036.
    PubMed     Text format     Abstract available


  399. STUBBS B, Williams J, Gaughran F, Craig T, et al
    How sedentary are people with psychosis? A systematic review and meta-analysis.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30037.
    PubMed     Text format     Abstract available


  400. HOFER A, Mizuno Y, Frajo-Apor B, Kemmler G, et al
    Resilience, internalized stigma, self-esteem, and hopelessness among people with schizophrenia: Cultural comparison in Austria and Japan.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30034.
    PubMed     Text format     Abstract available


  401. LABAD J, Barbero JD, Gutierrez-Zotes A, Montalvo I, et al
    Free thyroxine levels are associated with cognitive changes in individuals with a first episode of psychosis: A prospective 1-year follow-up study.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30026.
    PubMed     Text format     Abstract available


  402. LIU C, Xue Z, Palaniyappan L, Zhou L, et al
    Abnormally increased and incoherent resting-state activity is shared between patients with schizophrenia and their unaffected siblings.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30021.
    PubMed     Text format     Abstract available


  403. YOSHIDA K, Suzuki T, Imasaka Y, Kubo KI, et al
    Resilience in schizophrenia: A comparative study between a remote island and an urban area in Japan.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30033.
    PubMed     Text format     Abstract available


  404. TONNA M, Ottoni R, Paglia F, Ossola P, et al
    Obsessive-compulsive symptoms interact with disorganization in influencing social functioning in schizophrenia.
    Schizophr Res. 2016 Jan 20. pii: S0920-9964(16)30001.
    PubMed     Text format     Abstract available


  405. PARIKH V, Kutlu MG, Gould TJ
    nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.
    Schizophr Res. 2016 Jan 20. pii: S0920-9964(16)30018.
    PubMed     Text format     Abstract available


  406. TREEN D, Batlle S, Molla L, Forcadell E, et al
    Are there glutamate abnormalities in subjects at high risk mental state for psychosis? A review of the evidence.
    Schizophr Res. 2016 Jan 20. pii: S0920-9964(16)30002.
    PubMed     Text format     Abstract available


  407. KOH MT, Shao Y, Sherwood A, Smith DR, et al
    Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia.
    Schizophr Res. 2016 Jan 19. pii: S0920-9964(16)30023.
    PubMed     Text format     Abstract available


  408. SUN Y, Chen Y, Lee R, Bezerianos A, et al
    Disruption of brain anatomical networks in schizophrenia: A longitudinal, diffusion tensor imaging based study.
    Schizophr Res. 2016 Jan 19. pii: S0920-9964(16)30027.
    PubMed     Text format     Abstract available


  409. BRIDGMAN AC, Barr MS, Goodman MS, Chen R, et al
    Deficits in GABA receptor function and working memory in non-smokers with schizophrenia.
    Schizophr Res. 2016 Jan 18. pii: S0920-9964(16)30008.
    PubMed     Text format     Abstract available


  410. HAMAZAKI K, Maekawa M, Toyota T, Iwayama Y, et al
    Fatty acid composition and fatty acid binding protein expression in the postmortem frontal cortex of patients with schizophrenia: A case-control study.
    Schizophr Res. 2016 Jan 17. pii: S0920-9964(16)30014.
    PubMed     Text format     Abstract available


  411. PISKULIC D, Liu L, Cadenhead KS, Cannon TD, et al
    Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort.
    Schizophr Res. 2016 Jan 16. pii: S0920-9964(16)30020.
    PubMed     Text format     Abstract available


  412. KELLEY ME, Wan CR, Broussard B, Crisafio A, et al
    Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.
    Schizophr Res. 2016 Jan 16. pii: S0920-9964(16)30015.
    PubMed     Text format     Abstract available


  413. EKSTROM T, Maher S, Shinn A, Ongur D, et al
    Face identity discrimination in schizophrenia: Impairments to faces with high exposure in society.
    Schizophr Res. 2016 Jan 15. pii: S0920-9964(16)30009.
    PubMed     Text format    


  414. ALESSANDRINI M, Lancon C, Fond G, Faget-Agius C, et al
    A structural equation modelling approach to explore the determinants of quality of life in schizophrenia.
    Schizophr Res. 2016 Jan 15. pii: S0920-9964(16)30010.
    PubMed     Text format     Abstract available


  415. PENADES R, Pujol N, Catalan R, Masana G, et al
    Cortical thickness in regions of frontal and temporal lobes is associated with responsiveness to cognitive remediation therapy in schizophrenia.
    Schizophr Res. 2016 Jan 14. pii: S0920-9964(16)30004.
    PubMed     Text format     Abstract available


  416. WILSON C, Smith ME, Thompson E, Demro C, et al
    Context matters: The impact of neighborhood crime and paranoid symptoms on psychosis risk assessment.
    Schizophr Res. 2016 Jan 14. pii: S0920-9964(16)30007.
    PubMed     Text format     Abstract available


  417. YAKOVENKO I, Clark CM, Hodgins DC, Goghari VM, et al
    A qualitative analysis of the effects of a comorbid disordered gambling diagnosis with schizophrenia.
    Schizophr Res. 2016 Jan 14. pii: S0920-9964(15)30081.
    PubMed     Text format     Abstract available


  418. YAMANAKA H, Kanahara N, Suzuki T, Takase M, et al
    Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: An analysis of multi-factors predicting long-term prognosis.
    Schizophr Res. 2016 Jan 13. pii: S0920-9964(16)30013.
    PubMed     Text format     Abstract available


  419. CARNEY R, Cotter J, Bradshaw T, Firth J, et al
    Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2016 Jan 12. pii: S0920-9964(16)30012.
    PubMed     Text format     Abstract available


  420. KOIKE S, Satomura Y, Kawasaki S, Nishimura Y, et al
    Association between rostral prefrontal cortical activity and functional outcome in first-episode psychosis: a longitudinal functional near-infrared spectroscopy study.
    Schizophr Res. 2016 Jan 11. pii: S0920-9964(16)30006.
    PubMed     Text format     Abstract available


  421. VANCAMPFORT D, Stubbs B, Probst M, De Hert M, et al
    Physical activity as a vital sign in patients with schizophrenia: Evidence and clinical recommendations.
    Schizophr Res. 2016 Jan 9. pii: S0920-9964(16)30005.
    PubMed     Text format     Abstract available


  422. CHANG WC, Hui CL, Chan SK, Lee EH, et al
    Impact of avolition and cognitive impairment on functional outcome in first-episode schizophrenia-spectrum disorder: a prospective one-year follow-up study.
    Schizophr Res. 2016 Jan 9. pii: S0920-9964(16)30003.
    PubMed     Text format     Abstract available


  423. HETTIGE NC, Cole CB, Khalid S, De Luca V, et al
    Polygenic risk score prediction of antipsychotic dosage in schizophrenia.
    Schizophr Res. 2016 Jan 8. pii: S0920-9964(15)30087.
    PubMed     Text format     Abstract available


  424. MCCARTHY JM, Treadway MT, Bennett ME, Blanchard JJ, et al
    Inefficient effort allocation and negative symptoms in individuals with schizophrenia.
    Schizophr Res. 2016 Jan 4. pii: S0920-9964(15)30090.
    PubMed     Text format     Abstract available


  425. HOCHBERGER WC, Hill SK, Nelson CL, Reilly JL, et al
    Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.
    Schizophr Res. 2016;170:156-61.
    PubMed     Text format     Abstract available


    December 2015
  426. JAHN DR, Bennett ME, Park SG, Gur RE, et al
    The interactive effects of negative symptoms and social role functioning on suicide ideation in individuals with schizophrenia.
    Schizophr Res. 2015 Dec 30. pii: S0920-9964(15)30084.
    PubMed     Text format     Abstract available


  427. STRAUSS GP, Vertinski M, Vogel SJ, Ringdahl EN, et al
    Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the brief negative symptom scale across diagnostic categories.
    Schizophr Res. 2015 Dec 29. pii: S0920-9964(15)30088.
    PubMed     Text format     Abstract available


  428. ALPHS L, Mao L, Lynn Starr H, Benson C, et al
    A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia.
    Schizophr Res. 2015 Dec 29. pii: S0920-9964(15)30085.
    PubMed     Text format     Abstract available


  429. TSOUTSOULAS C, Mulsant BH, Kalache SM, Kumar S, et al
    The influence of medical burden severity and cognition on functional competence in older community-dwelling individuals with schizophrenia.
    Schizophr Res. 2015 Dec 24. pii: S0920-9964(15)30082.
    PubMed     Text format     Abstract available


  430. COLIZZI M, Carra E, Fraietta S, Lally J, et al
    Substance use, medication adherence and outcome one year following a first episode of psychosis.
    Schizophr Res. 2015 Dec 21. pii: S0920-9964(15)30058.
    PubMed     Text format     Abstract available


  431. REID MA, White DM, Kraguljac NV, Lahti AC, et al
    A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
    Schizophr Res. 2015 Dec 21. pii: S0920-9964(15)30076.
    PubMed     Text format     Abstract available


  432. COHEN AS, Callaway DA, Mitchell KR, Larsen JT, et al
    A temporal examination of co-activated emotion valence networks in schizophrenia and schizotypy.
    Schizophr Res. 2015 Dec 19. pii: S0920-9964(15)30083.
    PubMed     Text format     Abstract available


  433. LIU T, Zheng X
    Cultural revolution and onset of schizophrenia in China.
    Schizophr Res. 2015 Dec 17. pii: S0920-9964(15)30059.
    PubMed     Text format    


  434. PAKSARIAN D, Merikangas KR, Calkins ME, Gur RE, et al
    Racial-ethnic disparities in empirically-derived subtypes of subclinical psychosis among a U.S. sample of youths.
    Schizophr Res. 2015 Dec 17. pii: S0920-9964(15)30077.
    PubMed     Text format     Abstract available


  435. NANDA P, Tandon N, Mathew IT, Padmanabhan JL, et al
    Impulsivity across the psychosis spectrum: Correlates of cortical volume, suicidal history, and social and global function.
    Schizophr Res. 2015 Dec 17. pii: S0920-9964(15)30073.
    PubMed     Text format     Abstract available


  436. SHIM S, Shuman M, Duncan E
    An emerging role of cGMP in the treatment of schizophrenia: A review.
    Schizophr Res. 2015 Dec 16. pii: S0920-9964(15)30057.
    PubMed     Text format     Abstract available


  437. STRAUSS GP, Whearty KM, Morra LF, Sullivan SK, et al
    Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a Progressive Ratio task.
    Schizophr Res. 2015 Dec 14. pii: S0920-9964(15)30079.
    PubMed     Text format     Abstract available


  438. MAHER S, Mashhoon Y, Ekstrom T, Lukas S, et al
    Deficient cortical face-sensitive N170 responses and basic visual processing in schizophrenia.
    Schizophr Res. 2015 Dec 12. pii: S0920-9964(15)30078.
    PubMed     Text format     Abstract available


  439. LIZANO PL, Keshavan MS, Tandon N, Mathew IT, et al
    Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.
    Schizophr Res. 2015 Dec 11. pii: S0920-9964(15)30074.
    PubMed     Text format     Abstract available


  440. LYSTAD JU, Falkum E, Haaland VO, Bull H, et al
    Neurocognition and occupational functioning in schizophrenia spectrum disorders: The MATRICS Consensus Cognitive Battery (MCCB) and workplace assessments.
    Schizophr Res. 2015 Dec 11. pii: S0920-9964(15)30075.
    PubMed     Text format     Abstract available


  441. HELLE S, Ringen PA, Melle I, Larsen TK, et al
    Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).
    Schizophr Res. 2015 Dec 9. pii: S0920-9964(15)30070.
    PubMed     Text format     Abstract available


  442. WANG X, Yu X, Appelbaum PS, Tang H, et al
    Longitudinal informed consent competency in stable community patients with schizophrenia: A one-week training and one-year follow-up study.
    Schizophr Res. 2015 Dec 8. pii: S0920-9964(15)30062.
    PubMed     Text format     Abstract available


  443. CHI MH, Hsiao CY, Chen KC, Lee LT, et al
    The readmission rate and medical cost of patients with schizophrenia after first hospitalization - A 10-year follow-up population-based study.
    Schizophr Res. 2015 Dec 8. pii: S0920-9964(15)30068.
    PubMed     Text format     Abstract available


  444. ENGEL M, Fritzsche A, Lincoln TM
    Anticipation and experience of emotions in patients with schizophrenia and negative symptoms. An experimental study in a social context.
    Schizophr Res. 2015 Dec 7. pii: S0920-9964(15)30071.
    PubMed     Text format     Abstract available


  445. SHASTEEN JR, Pinkham AE, Kelsven S, Ludwig K, et al
    Intact implicit processing of facial threat cues in schizophrenia.
    Schizophr Res. 2015 Dec 7. pii: S0920-9964(15)30072.
    PubMed     Text format     Abstract available


  446. DU Y, Pearlson GD, Yu Q, He H, et al
    Interaction among subsystems within default mode network diminished in schizophrenia patients: A dynamic connectivity approach.
    Schizophr Res. 2015 Dec 3. pii: S0920-9964(15)30064.
    PubMed     Text format     Abstract available


    November 2015
  447. RAMAGE EM, Klimas N, Vogel SJ, Vertinski M, et al
    Concurrent sound segregation impairments in schizophrenia: The contribution of auditory-specific and general cognitive factors.
    Schizophr Res. 2015 Nov 28. pii: S0920-9964(15)30066.
    PubMed     Text format     Abstract available


  448. LIN A, Wardenaar KJ, Pontillo M, De Crescenzo F, et al
    Is it still correct to differentiate between early and very early onset psychosis?
    Schizophr Res. 2015 Nov 27. pii: S0920-9964(15)30063.
    PubMed     Text format     Abstract available


  449. VINK M, de Leeuw M, Pouwels R, van den Munkhof HE, et al
    Diminishing striatal activation across adolescent development during reward anticipation in offspring of schizophrenia patients.
    Schizophr Res. 2015 Nov 26. pii: S0920-9964(15)30061.
    PubMed     Text format     Abstract available


  450. MYLES H, Myles N, Antic NA, Adams R, et al
    Obstructive sleep apnea and schizophrenia: A systematic review to inform clinical practice.
    Schizophr Res. 2015 Nov 24. pii: S0920-9964(15)30060.
    PubMed     Text format     Abstract available


  451. MALAN-MULLER S, Kilian S, van den Heuvel LL, Bardien S, et al
    A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.
    Schizophr Res. 2015 Nov 24. pii: S0920-9964(15)30054.
    PubMed     Text format     Abstract available


  452. BRENT BK, Rosso IM, Thermenos HW, Holt DJ, et al
    Alterations of lateral temporal cortical gray matter and facial memory as vulnerability indicators for schizophrenia: An MRI study in youth at familial high-risk for schizophrenia.
    Schizophr Res. 2015 Nov 24. pii: S0920-9964(15)30056.
    PubMed     Text format     Abstract available


  453. WATANUKI T, Matsuo K, Egashira K, Nakashima M, et al
    Precentral and inferior prefrontal hypoactivation during facial emotion recognition in patients with schizophrenia: A functional near-infrared spectroscopy study.
    Schizophr Res. 2015 Nov 20. pii: S0920-9964(15)30055.
    PubMed     Text format     Abstract available


  454. DICKERSON F, Origoni A, Schroeder J, Schweinfurth LA, et al
    Mortality in schizophrenia and bipolar disorder: Clinical and serological predictors.
    Schizophr Res. 2015 Nov 19. pii: S0920-9964(15)30053.
    PubMed     Text format     Abstract available


  455. GAEBEL W, Riesbeck M, Wolwer W, Klimke A, et al
    Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia.
    Schizophr Res. 2015 Nov 19. pii: S0920-9964(15)30024.
    PubMed     Text format     Abstract available


  456. ZHANG XY, Chen DC, Tan YL, Tan SP, et al
    BDNF polymorphisms are associated with schizophrenia onset and positive symptoms.
    Schizophr Res. 2015 Nov 18. pii: S0920-9964(15)30052.
    PubMed     Text format     Abstract available


  457. EMAMI S, Guimond S, Mallar Chakravarty M, Lepage M, et al
    Cortical thickness and low insight into symptoms in enduring schizophrenia.
    Schizophr Res. 2015 Nov 18. pii: S0920-9964(15)30016.
    PubMed     Text format     Abstract available


  458. VANMEERTEN NJ, Dubke RE, Stanwyck JJ, Kang SS, et al
    Abnormal early brain responses during visual search are evident in schizophrenia but not bipolar affective disorder.
    Schizophr Res. 2015 Nov 18. pii: S0920-9964(15)30050.
    PubMed     Text format     Abstract available


  459. GREENWOOD TA, Lazzeroni LC, Calkins ME, Freedman R, et al
    Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study.
    Schizophr Res. 2015 Nov 17. pii: S0920-9964(15)30051.
    PubMed     Text format     Abstract available


  460. BREITBORDE NJ, Dawley D, Bell EK, Vanuk JR, et al
    A personalized paced-breathing intervention to increase heart rate variability among individuals with first-episode psychosis following stress exposure.
    Schizophr Res. 2015 Nov 16. pii: S0920-9964(15)30048.
    PubMed     Text format    


  461. BERNA F, Misdrahi D, Boyer L, Aouizerate B, et al
    Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset.
    Schizophr Res. 2015 Nov 15. pii: S0920-9964(15)30040.
    PubMed     Text format     Abstract available


  462. FAN N, Luo Y, Xu K, Zhang M, et al
    Relationship of serum levels of TNF-alpha, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30049.
    PubMed     Text format     Abstract available


  463. KEINANEN J, Mantere O, Kieseppa T, Mantyla T, et al
    Early insulin resistance predicts weight gain and waist circumference increase in first-episode psychosis - A one year follow-up study.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30045.
    PubMed     Text format    


  464. KOGA M, Serritella AV, Sawa A, Sedlak TW, et al
    Implications for reactive oxygen species in schizophrenia pathogenesis.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)00337.
    PubMed     Text format     Abstract available


  465. LYNGBERG K, Buchy L, Liu L, Perkins D, et al
    Patterns of premorbid functioning in individuals at clinical high risk of psychosis.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30047.
    PubMed     Text format     Abstract available


  466. HEALD A, Sein K, Anderson S, Pendlebury J, et al
    Diet, exercise and the metabolic syndrome in schizophrenia: A cross-sectional study.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30043.
    PubMed     Text format    


  467. MAUNEY SA, Pietersen CY, Sonntag KC, Woo TW, et al
    Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30042.
    PubMed     Text format     Abstract available


  468. SCHAEFFER DJ, Rodrigue AL, Burton CR, Pierce JE, et al
    White matter structural integrity differs between people with schizophrenia and healthy groups as a function of cognitive control.
    Schizophr Res. 2015 Nov 13. pii: S0920-9964(15)30044.
    PubMed     Text format     Abstract available


  469. MUNOZ-NEGRO JE, Ibanez-Casas I, de Portugal E, Ochoa S, et al
    A dimensional comparison between delusional disorder, schizophrenia and schizoaffective disorder.
    Schizophr Res. 2015 Nov 13. pii: S0920-9964(15)30039.
    PubMed     Text format    


  470. KRAAN T, van Dam DS, Velthorst E, de Ruigh EL, et al
    Childhood trauma and clinical outcome in patients at ultra-high risk of transition to psychosis.
    Schizophr Res. 2015 Nov 13. pii: S0920-9964(15)30026.
    PubMed     Text format    


  471. KANAAN RA
    Concerns over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia.
    Schizophr Res. 2015 Nov 8. pii: S0920-9964(15)30009.
    PubMed     Text format    


  472. TAN Y, Li Y, Tan S, Wang Z, et al
    Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia.
    Schizophr Res. 2015 Nov 5. pii: S0920-9964(15)30038.
    PubMed     Text format     Abstract available


  473. GONZALEZ-HEYDRICH J, Bosquet Enlow M, D'Angelo E, Seidman LJ, et al
    Early auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sample.
    Schizophr Res. 2015 Nov 5. pii: S0920-9964(15)30037.
    PubMed     Text format     Abstract available


  474. KRAEUTER AK, Loxton H, Lima BC, Rudd D, et al
    Ketogenic diet reverses behavioral abnormalities in an acute NMDA receptor hypofunction model of schizophrenia.
    Schizophr Res. 2015 Nov 4. pii: S0920-9964(15)30041.
    PubMed     Text format    


  475. HIRJAK D, Thomann PA, Kubera KM, Wolf ND, et al
    Motor dysfunction within the schizophrenia-spectrum: A dimensional step towards an underappreciated domain.
    Schizophr Res. 2015 Nov 4. pii: S0920-9964(15)30022.
    PubMed     Text format    


  476. SCHLIER B, Jaya ES, Moritz S, Lincoln TM, et al
    The Community Assessment of Psychic Experiences measures nine clusters of psychosis-like experiences: A validation of the German version of the CAPE.
    Schizophr Res. 2015 Nov 3. pii: S0920-9964(15)30034.
    PubMed     Text format     Abstract available


  477. CESKOVA E, Prikryl R, Libiger J, Svancara J, et al
    Gender differences in the treatment of first-episode schizophrenia: Results from the European First Episode Schizophrenia Trial.
    Schizophr Res. 2015 Nov 3. pii: S0920-9964(15)30013.
    PubMed     Text format    


  478. DEAN B, Thomas N, Lai CY, Chen WJ, et al
    Changes in cholinergic and glutamatergic markers in the striatum from a sub-set of subjects with schizophrenia.
    Schizophr Res. 2015 Nov 3. pii: S0920-9964(15)30029.
    PubMed     Text format     Abstract available


  479. VENDRAMINI PH, Gattaz WF, Schmitt A, Falkai P, et al
    Pioneering ambient mass spectrometry imaging in psychiatry: Potential for new insights into schizophrenia.
    Schizophr Res. 2015 Nov 3. pii: S0920-9964(15)30019.
    PubMed     Text format    


    October 2015
  480. SCHLOSSER DA, Campellone TR, Biagianti B, Delucchi KL, et al
    Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.
    Schizophr Res. 2015 Oct 31. pii: S0920-9964(15)30036.
    PubMed     Text format     Abstract available


  481. CLAMOR A, Schlier B, Kother U, Hartmann MM, et al
    Bridging psychophysiological and phenomenological characteristics of psychosis - Preliminary evidence for the relevance of emotion regulation.
    Schizophr Res. 2015 Oct 31. pii: S0920-9964(15)30035.
    PubMed     Text format     Abstract available


  482. DE BRITO RB, de Carvalho Araujo L, Diniz MJ, de Castro Georg R, et al
    The CYP1A2 -163C>A polymorphism is associated with super-refractory schizophrenia.
    Schizophr Res. 2015 Oct 31. pii: S0920-9964(15)30018.
    PubMed     Text format    


  483. JUKURI T, Kiviniemi V, Nikkinen J, Miettunen J, et al
    Cerebellar activity in young people with familial risk for psychosis - The Oulu Brain and Mind Study.
    Schizophr Res. 2015 Oct 30. pii: S0920-9964(15)30010.
    PubMed     Text format     Abstract available


  484. NARAYANAN SS, Bhatia T, Velligan DI, Nimgaonkar VL, et al
    A case control study of association between cognition and functional capacity in schizophrenia.
    Schizophr Res. 2015 Oct 30. pii: S0920-9964(15)30025.
    PubMed     Text format     Abstract available


  485. HONG SB, Lee TY, Kwak YB, Kim SN, et al
    Baseline putamen volume as a predictor of positive symptom reduction in patients at clinical high risk for psychosis: A preliminary study.
    Schizophr Res. 2015 Oct 30. pii: S0920-9964(15)30030.
    PubMed     Text format     Abstract available


  486. HARTMANN-RIEMER MN, Hager OM, Kirschner M, Bischof M, et al
    The association of neurocognitive impairment with diminished expression and apathy in schizophrenia.
    Schizophr Res. 2015 Oct 30. pii: S0920-9964(15)30032.
    PubMed     Text format    


  487. ARMANDO M, Pontillo M, De Crescenzo F, Mazzone L, et al
    Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.
    Schizophr Res. 2015 Oct 29. pii: S0920-9964(15)30033.
    PubMed     Text format     Abstract available


  488. OSTEFJELLS T, Melle I, Hagen R, Romm KL, et al
    Unhelpful metacognitive beliefs in early psychosis are associated with affective symptoms and childhood social adjustment.
    Schizophr Res. 2015 Oct 28. pii: S0920-9964(15)30027.
    PubMed     Text format     Abstract available


  489. BORDA JP, Sass LA
    Phenomenology and neurobiology of self disorder in schizophrenia: Primary factors.
    Schizophr Res. 2015 Oct 26. pii: S0920-9964(15)00519.
    PubMed     Text format    


  490. TONIN FS, Piazza T, Wiens A, Fernandez-Llimos F, et al
    Adverse events and treatment failure leading to discontinuation of recently approved antipsychotic drugs in schizophrenia: A network meta-analysis.
    Schizophr Res. 2015 Oct 26. pii: S0920-9964(15)00489.
    PubMed     Text format    


  491. BEHDINAN T, Foussias G, Wheeler AL, Stefanik L, et al
    Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up.
    Schizophr Res. 2015 Oct 23. pii: S0920-9964(15)30023.
    PubMed     Text format     Abstract available


  492. SASS LA, Borda JP
    Phenomenology and neurobiology of self disorder in schizophrenia: Secondary factors.
    Schizophr Res. 2015 Oct 23. pii: S0920-9964(15)00520.
    PubMed     Text format    


  493. MAMAH D, Wen J, Luo J, Ulrich X, et al
    Subcomponents of brain T2* relaxation in schizophrenia, bipolar disorder and siblings: A Gradient Echo Plural Contrast Imaging (GEPCI) study.
    Schizophr Res. 2015 Oct 23. pii: S0920-9964(15)30004.
    PubMed     Text format     Abstract available


  494. DEAN DJ, Orr JM, Newberry RE, Mittal VA, et al
    Motor behavior reflects reduced hemispheric asymmetry in the psychosis risk period.
    Schizophr Res. 2015 Oct 19. pii: S0920-9964(15)30017.
    PubMed     Text format     Abstract available


  495. WEISER M, Kapara O, Werbeloff N, Goldberg S, et al
    A population-based longitudinal study of suicide risk in male schizophrenia patients: Proximity to hospital discharge and the moderating effect of premorbid IQ.
    Schizophr Res. 2015 Oct 17. pii: S0920-9964(15)30006.
    PubMed     Text format     Abstract available


  496. ATHANAS KM, Mauney SL, Woo TW
    Increased extracellular clusterin in the prefrontal cortex in schizophrenia.
    Schizophr Res. 2015 Oct 16. pii: S0920-9964(15)30002.
    PubMed     Text format     Abstract available


  497. CHEN VC, Liao YT, Lai TJ, Lane HY, et al
    Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study.
    Schizophr Res. 2015 Oct 15. pii: S0920-9964(15)30005.
    PubMed     Text format     Abstract available


  498. KAPELSKI P, Skibinska M, Maciukiewicz M, Wilkosc M, et al
    Association study of functional polymorphisms in interleukins and interleukin receptors genes: IL1A, IL1B, IL1RN, IL6, IL6R, IL10, IL10RA and TGFB1 in schizophrenia in Polish population.
    Schizophr Res. 2015 Oct 15. pii: S0920-9964(15)30008.
    PubMed     Text format    


  499. BEST MW, Bowie CR
    Neurophysiological evidence for a processing bias towards schizophrenia-associated communication abnormalities.
    Schizophr Res. 2015 Oct 14. pii: S0920-9964(15)30003.
    PubMed     Text format     Abstract available


  500. SHARMA RP, Feiner B, Chase KA
    Histone H3 phosphorylation is upregulated in PBMCs of schizophrenia patients in comparison to healthy controls.
    Schizophr Res. 2015 Oct 14. pii: S0920-9964(15)00527.
    PubMed     Text format    


  501. VANCAMPFORT D, Rosenbaum S, Ward PB, Stubbs B, et al
    Exercise improves cardiorespiratory fitness in people with schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2015 Oct 13. pii: S0920-9964(15)00524.
    PubMed     Text format    


  502. ZHANG B, Guan F, Chen G, Lin H, et al
    Common variants in SLC1A2 and schizophrenia: Association and cognitive function in patients with schizophrenia and healthy individuals.
    Schizophr Res. 2015 Oct 9. pii: S0920-9964(15)30012.
    PubMed     Text format     Abstract available


  503. BACHILLER A, Romero S, Molina V, Alonso JF, et al
    Auditory P3a and P3b neural generators in schizophrenia: An adaptive sLORETA P300 localization approach.
    Schizophr Res. 2015 Oct 5. pii: S0920-9964(15)00523.
    PubMed     Text format     Abstract available


  504. WU CH, Hwang TJ, Chen YJ, Hsu YC, et al
    Primary and secondary alterations of white matter connectivity in schizophrenia: A study on first-episode and chronic patients using whole-brain tractography-based analysis.
    Schizophr Res. 2015 Oct 3. pii: S0920-9964(15)00493.
    PubMed     Text format     Abstract available


  505. WU BJ, Lan TH, Hu TM, Lee SM, et al
    Validation of a five-factor model of a Chinese Mandarin version of the Positive and Negative Syndrome Scale (CMV-PANSS) in a sample of 813 schizophrenia patients.
    Schizophr Res. 2015 Oct 3. pii: S0920-9964(15)00481.
    PubMed     Text format     Abstract available


  506. MINOR KS, Marggraf MP, Davis BJ, Luther L, et al
    Conceptual disorganization weakens links in cognitive pathways: Disentangling neurocognition, social cognition, and metacognition in schizophrenia.
    Schizophr Res. 2015 Oct 2. pii: S0920-9964(15)00521.
    PubMed     Text format     Abstract available


  507. EMSLEY R, Asmal L, du Plessis S, Chiliza B, et al
    Dorsal striatal volumes in never-treated patients with first-episode schizophrenia before and during acute treatment.
    Schizophr Res. 2015 Oct 2. pii: S0920-9964(15)00484.
    PubMed     Text format     Abstract available


  508. PERKINS DO, Jeffries CD, Cornblatt BA, Woods SW, et al
    Severity of thought disorder predicts psychosis in persons at clinical high-risk.
    Schizophr Res. 2015 Oct 2. pii: S0920-9964(15)00478.
    PubMed     Text format     Abstract available


  509. CASTELLANI CA, Melka MG, Gui JL, O'Reilly RL, et al
    Integration of DNA sequence and DNA methylation changes in monozygotic twin pairs discordant for schizophrenia.
    Schizophr Res. 2015 Oct 2. pii: S0920-9964(15)00491.
    PubMed     Text format     Abstract available


  510. VAN HAREN NE, Schnack HG, Koevoets MG, Cahn W, et al
    Trajectories of subcortical volume change in schizophrenia: A 5-year follow-up.
    Schizophr Res. 2015 Oct 1. pii: S0920-9964(15)00522.
    PubMed     Text format    


    September 2015
  511. SCHREINER A, Aadamsoo K, Altamura AC, Franco M, et al
    Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia.
    Schizophr Res. 2015 Sep 29. pii: S0920-9964(15)00444.
    PubMed     Text format     Abstract available


  512. HARO JM, Altamura C, Corral R, Elkis H, et al
    Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study.
    Schizophr Res. 2015 Sep 29. pii: S0920-9964(15)00470.
    PubMed     Text format     Abstract available


  513. NORMAN RM, Manchanda R, Harricharan R, Northcott S, et al
    The course of negative symptoms over the first five years of treatment: Data from an early intervention program for psychosis.
    Schizophr Res. 2015 Sep 29. pii: S0920-9964(15)00480.
    PubMed     Text format     Abstract available


  514. MOORE RC, Harmell AL, Harvey PD, Bowie CR, et al
    Improving the understanding of the link between cognition and functional capacity in schizophrenia and bipolar disorder.
    Schizophr Res. 2015 Sep 28. pii: S0920-9964(15)00487.
    PubMed     Text format     Abstract available


  515. GRATTAN RE, Morton SE, Warhurst ES, Parker TR, et al
    Paternal and maternal ages have contrasting associations with self-reported schizophrenia liability.
    Schizophr Res. 2015 Sep 26. pii: S0920-9964(15)00488.
    PubMed     Text format     Abstract available


  516. HARGREAVES A, Dillon R, Anderson-Schmidt H, Corvin A, et al
    Computerised working-memory focused cognitive remediation therapy for psychosis - A preliminary study.
    Schizophr Res. 2015 Sep 25. pii: S0920-9964(15)00473.
    PubMed     Text format     Abstract available


  517. RODRIGUEZ-JIMENEZ R, Dompablo M, Bagney A, Santabarbara J, et al
    The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning.
    Schizophr Res. 2015 Sep 24. pii: S0920-9964(15)00483.
    PubMed     Text format     Abstract available


  518. KENNEY J, Anderson-Schmidt H, Scanlon C, Arndt S, et al
    Cognitive course in first-episode psychosis and clinical correlates: A 4year longitudinal study using the MATRICS Consensus Cognitive Battery.
    Schizophr Res. 2015 Sep 23. pii: S0920-9964(15)00476.
    PubMed     Text format     Abstract available


  519. CHEUNG EF, Lui SS, Wang Y, Yang TX, et al
    Time-based but not event-based prospective memory remains impaired one year after the onset of schizophrenia: A prospective study.
    Schizophr Res. 2015 Sep 21. pii: S0920-9964(15)00485.
    PubMed     Text format     Abstract available


  520. YU HY, Hsiao CY, Chen KC, Lee LT, et al
    A comparison of the effectiveness of risperidone, haloperidol and flupentixol long-acting injections in patients with schizophrenia-A nationwide study.
    Schizophr Res. 2015 Sep 19. pii: S0920-9964(15)00475.
    PubMed     Text format     Abstract available


  521. HELLDIN L, Hjarthag F, Olsson AK, Harvey PD, et al
    Cognitive performance, symptom severity, and survival among patients with schizophrenia spectrum disorder: A prospective 15-year study.
    Schizophr Res. 2015 Sep 18. pii: S0920-9964(15)00479.
    PubMed     Text format    


  522. ZANINI MA, Castro J, Cunha GR, Asevedo E, et al
    Abnormalities in sleep patterns in individuals at risk for psychosis and bipolar disorder.
    Schizophr Res. 2015 Sep 18. pii: S0920-9964(15)00452.
    PubMed     Text format     Abstract available


  523. FERVAHA G, Foussias G, Takeuchi H, Agid O, et al
    Measuring motivation in people with schizophrenia.
    Schizophr Res. 2015 Sep 18. pii: S0920-9964(15)00482.
    PubMed     Text format     Abstract available


  524. O'DONOGHUE B, Yung AR, Wood S, Thompson A, et al
    Neighbourhood characteristics and the rate of identification of young people at ultra-high risk for psychosis.
    Schizophr Res. 2015 Sep 18. pii: S0920-9964(15)00471.
    PubMed     Text format     Abstract available


  525. LUTHER L, Lysaker PH, Firmin RL, Breier A, et al
    Intrinsic motivation and amotivation in first episode and prolonged psychosis.
    Schizophr Res. 2015 Sep 16. pii: S0920-9964(15)00469.
    PubMed     Text format     Abstract available


  526. MCCOLLUM LA, Roberts RC
    Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters.
    Schizophr Res. 2015 Sep 16. pii: S0920-9964(15)00477.
    PubMed     Text format     Abstract available


  527. UCOK A, Kaya H, Ugurpala C, Cikrikcili U, et al
    History of childhood physical trauma is related to cognitive decline in individuals with ultra-high risk for psychosis.
    Schizophr Res. 2015 Sep 16. pii: S0920-9964(15)00467.
    PubMed     Text format    


  528. LI X, Black M, Xia S, Zhan C, et al
    Subcortical structure alterations impact language processing in individuals with schizophrenia and those at high genetic risk.
    Schizophr Res. 2015 Sep 16. pii: S0920-9964(15)00420.
    PubMed     Text format     Abstract available


  529. LIU J, Siyahhan Julnes P, Chen J, Ehrlich S, et al
    The association of DNA methylation and brain volume in healthy individuals and schizophrenia patients.
    Schizophr Res. 2015 Sep 14. pii: S0920-9964(15)00464.
    PubMed     Text format     Abstract available


  530. SCHARKO AM
    Cat ownership and schizophrenia.
    Schizophr Res. 2015 Sep 12. pii: S0920-9964(15)00426.
    PubMed     Text format    


  531. GONZALEZ-CASTRO TB, Tovilla-Zarate CA, Hernandez-Diaz Y, Fresan A, et al
    No association between ApoE and schizophrenia: Evidence of systematic review and updated meta-analysis.
    Schizophr Res. 2015 Sep 11. pii: S0920-9964(15)00460.
    PubMed     Text format     Abstract available


  532. HARING L, Koido K, Vasar V, Leping V, et al
    Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
    Schizophr Res. 2015 Sep 10. pii: S0920-9964(15)00456.
    PubMed     Text format     Abstract available


  533. TSO IF, Fang Y, Phan KL, Welsh RC, et al
    Abnormal GABAergic function and face processing in schizophrenia: A pharmacologic-fMRI study.
    Schizophr Res. 2015 Sep 9. pii: S0920-9964(15)00451.
    PubMed     Text format     Abstract available


  534. SANCHEZ-GISTAU V, Romero S, Moreno D, de la Serna E, et al
    Psychiatric disorders in child and adolescent offspring of patients with schizophrenia and bipolar disorder: A controlled study.
    Schizophr Res. 2015 Sep 9. pii: S0920-9964(15)00463.
    PubMed     Text format     Abstract available


  535. SHYU YC, Yuan SS, Lee SY, Yang CJ, et al
    Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
    Schizophr Res. 2015 Sep 9. pii: S0920-9964(15)00462.
    PubMed     Text format     Abstract available


  536. HAGER OM, Kirschner M, Bischof M, Hartmann-Riemer MN, et al
    Reward-dependent modulation of working memory is associated with negative symptoms in schizophrenia.
    Schizophr Res. 2015 Sep 8. pii: S0920-9964(15)00453.
    PubMed     Text format     Abstract available


  537. RIEHLE M, Jung E, Wiesjahn M, Mehl S, et al
    What's in an item? Predicting social outcomes in schizophrenia spectrum disorders from the PANSS item "Poor Rapport".
    Schizophr Res. 2015 Sep 8. pii: S0920-9964(15)00455.
    PubMed     Text format    


  538. ROGNLI EB, Berge J, Hakansson A, Bramness JG, et al
    Long-term risk factors for substance-induced and primary psychosis after release from prison. A longitudinal study of substance users.
    Schizophr Res. 2015 Sep 8. pii: S0920-9964(15)00461.
    PubMed     Text format     Abstract available


  539. VALMAGGIA LR, Day FL, Kroll J, Laing J, et al
    Bullying victimisation and paranoid ideation in people at ultra high risk for psychosis.
    Schizophr Res. 2015 Sep 5. pii: S0920-9964(15)00458.
    PubMed     Text format     Abstract available


  540. JOSEPH J, Depp C, Martin AS, Daly RE, et al
    Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups.
    Schizophr Res. 2015 Sep 2. pii: S0920-9964(15)00448.
    PubMed     Text format     Abstract available


  541. EDWARDS CJ, Cella M, Tarrier N, Wykes T, et al
    Investigating the empirical support for therapeutic targets proposed by the temporal experience of pleasure model in schizophrenia: A systematic review.
    Schizophr Res. 2015 Sep 2. pii: S0920-9964(15)00432.
    PubMed     Text format     Abstract available


  542. SUM MY, Ho NF, Sim K
    Cross diagnostic comparisons of quality of life deficits in remitted and unremitted patients with schizophrenia and bipolar disorder.
    Schizophr Res. 2015 Sep 1. pii: S0920-9964(15)00459.
    PubMed     Text format     Abstract available


  543. PEDERSEN CB
    Persons with schizophrenia migrate towards urban areas due to the development of their disorder or its prodromata.
    Schizophr Res. 2015 Sep 1. pii: S0920-9964(15)00457.
    PubMed     Text format     Abstract available


    August 2015
  544. GOLDEN LE, Sassoon P, Caceda R
    A case report of late onset psychosis with dementia and aspirin and caffeine addiction.
    Schizophr Res. 2015 Aug 31. pii: S0920-9964(15)00450.
    PubMed     Text format    


  545. TIJMS BM, Sprooten E, Job D, Johnstone EC, et al
    Grey matter networks in people at increased familial risk for schizophrenia.
    Schizophr Res. 2015 Aug 29. pii: S0920-9964(15)00454.
    PubMed     Text format     Abstract available


  546. YAMADA K, Hattori E, Iwayama Y, Toyota T, et al
    Population-dependent contribution of the major histocompatibility complex region to schizophrenia susceptibility.
    Schizophr Res. 2015 Aug 28. pii: S0920-9964(15)00447.
    PubMed     Text format     Abstract available


  547. YANG LH, Link BG, Ben-David S, Gill KE, et al
    Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis.
    Schizophr Res. 2015 Aug 24. pii: S0920-9964(15)00423.
    PubMed     Text format     Abstract available


  548. WHITE DA, Luther L, Bonfils KA, Salyers MP, et al
    Essential components of early intervention programs for psychosis: Available intervention services in the United States.
    Schizophr Res. 2015 Aug 22. pii: S0920-9964(15)00449.
    PubMed     Text format     Abstract available


  549. REVELL ER, Neill JC, Harte M, Khan Z, et al
    A systematic review and meta-analysis of cognitive remediation in early schizophrenia.
    Schizophr Res. 2015 Aug 21. pii: S0920-9964(15)00446.
    PubMed     Text format     Abstract available


  550. HAUT KM, Karlsgodt KH, Bilder RM, Congdon E, et al
    Memory systems in schizophrenia: Modularity is preserved but deficits are generalized.
    Schizophr Res. 2015 Aug 20. pii: S0920-9964(15)00433.
    PubMed     Text format     Abstract available


  551. CHENG H, Newman S, Goni J, Kent JS, et al
    Nodal centrality of functional network in the differentiation of schizophrenia.
    Schizophr Res. 2015 Aug 20. pii: S0920-9964(15)00430.
    PubMed     Text format     Abstract available


  552. SPAGNA A, Dong Y, Mackie MA, Li M, et al
    Clozapine improves the orienting of attention in schizophrenia.
    Schizophr Res. 2015 Aug 19. pii: S0920-9964(15)00428.
    PubMed     Text format     Abstract available


  553. DICKERSON F, Schroeder J, Stallings C, Origoni A, et al
    Multianalyte markers of schizophrenia and bipolar disorder: A preliminary study.
    Schizophr Res. 2015 Aug 19. pii: S0920-9964(15)00422.
    PubMed     Text format     Abstract available


  554. GIANNITELLI M, Xavier J, Francois A, Bodeau N, et al
    Facial, vocal and cross-modal emotion processing in early-onset schizophrenia spectrum disorders.
    Schizophr Res. 2015 Aug 18. pii: S0920-9964(15)00405.
    PubMed     Text format     Abstract available


  555. VUKADINOVIC Z
    Sleep spindle reductions in schizophrenia and its implications for the development of cortical body map.
    Schizophr Res. 2015 Aug 15. pii: S0920-9964(15)00431.
    PubMed     Text format    


  556. BERGON A, Belzeaux R, Comte M, Pelletier F, et al
    CX3CR1 is dysregulated in blood and brain from schizophrenia patients.
    Schizophr Res. 2015 Aug 15. pii: S0920-9964(15)00429.
    PubMed     Text format     Abstract available


  557. ZHANG Y, Zheng J, Fan X, Guo X, et al
    Dysfunctional resting-state connectivities of brain regions with structural deficits in drug-naive first-episode schizophrenia adolescents.
    Schizophr Res. 2015 Aug 15. pii: S0920-9964(15)00396.
    PubMed     Text format     Abstract available


  558. WOLF PJ, Hamilton FE
    Flawed analyses undermine proposed relationship between childhood cat ownership and schizophrenia.
    Schizophr Res. 2015 Aug 14. pii: S0920-9964(15)00427.
    PubMed     Text format    


  559. NYBOE L, Vestergaard CH, Moeller MK, Lund H, et al
    Metabolic syndrome and aerobic fitness in patients with first-episode schizophrenia, including a 1-year follow-up.
    Schizophr Res. 2015 Aug 13. pii: S0920-9964(15)00419.
    PubMed     Text format     Abstract available


  560. HOLPER L, Aleksandrowicz A, Muller M, Ajdacic-Gross V, et al
    Brain correlates of verbal fluency in subthreshold psychosis assessed by functional near-infrared spectroscopy.
    Schizophr Res. 2015 Aug 13. pii: S0920-9964(15)00409.
    PubMed     Text format     Abstract available


  561. LI Q, Xiang YT, Su YA, Shu L, et al
    Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
    Schizophr Res. 2015 Aug 12. pii: S0920-9964(15)00414.
    PubMed     Text format     Abstract available


  562. TAKAHASHI S, Glatt SJ, Uchiyama M, Faraone SV, et al
    Meta-analysis of data from the Psychiatric Genomics Consortium and additional samples supports association of CACNA1C with risk for schizophrenia.
    Schizophr Res. 2015 Aug 11. pii: S0920-9964(15)00398.
    PubMed     Text format     Abstract available


  563. VALMAGGIA LR, Day F, Garety P, Freeman D, et al
    Social defeat predicts paranoid appraisals in people at high risk for psychosis.
    Schizophr Res. 2015 Aug 11. pii: S0920-9964(15)00416.
    PubMed     Text format     Abstract available


  564. AUSTIN SF, Mors O, Budtz-Jorgensen E, Secher RG, et al
    Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10year follow-up study in the OPUS cohort.
    Schizophr Res. 2015 Aug 8. pii: S0920-9964(15)00386.
    PubMed     Text format     Abstract available


  565. ARNOLD C, Allott K, Farhall J, Killackey E, et al
    Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
    Schizophr Res. 2015 Aug 7. pii: S0920-9964(15)00417.
    PubMed     Text format     Abstract available


  566. ROCHE E, Lyne JP, O'Donoghue B, Segurado R, et al
    The factor structure and clinical utility of formal thought disorder in first episode psychosis.
    Schizophr Res. 2015 Aug 7. pii: S0920-9964(15)00415.
    PubMed     Text format     Abstract available


  567. WANG X, Li F, Zheng H, Wang W, et al
    Breakdown of the striatal-default mode network loop in schizophrenia.
    Schizophr Res. 2015 Aug 7. pii: S0920-9964(15)00392.
    PubMed     Text format     Abstract available


  568. EGBUJO CN, Sinclair D, Borgmann-Winter KE, Arnold SE, et al
    Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.
    Schizophr Res. 2015 Aug 7. pii: S0920-9964(15)00391.
    PubMed     Text format     Abstract available


  569. GODIN O, Leboyer M, Gaman A, Aouizerate B, et al
    Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort.
    Schizophr Res. 2015 Aug 6. pii: S0920-9964(15)00413.
    PubMed     Text format     Abstract available


  570. KOOLA MM, Sullivan KM, Earl AK, Feldman SM, et al
    Undiagnosed Lyme disease in adults with schizophrenia.
    Schizophr Res. 2015 Aug 6. pii: S0920-9964(15)00359.
    PubMed     Text format    


  571. SMESNY S, Gussew A, Biesel NJ, Schack S, et al
    Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
    Schizophr Res. 2015 Aug 6. pii: S0920-9964(15)00352.
    PubMed     Text format     Abstract available


  572. KOYANAGI A, Stickley A, Haro JM
    Subclinical psychosis and suicidal behavior in England: Findings from the 2007 Adult Psychiatric Morbidity Survey.
    Schizophr Res. 2015 Aug 6. pii: S0920-9964(15)00407.
    PubMed     Text format     Abstract available


  573. LINDENMAYER JP, Khan A, Lachman H, McGurk SR, et al
    COMT genotype and response to cognitive remediation in schizophrenia.
    Schizophr Res. 2015 Aug 6. pii: S0920-9964(15)00403.
    PubMed     Text format     Abstract available


  574. BENES FM
    GUEST EDITORIAL The GABA System in Schizophrenia: Cells, Molecules and Microcircuitry Francine M. Benes, M.D., Ph.D.
    Schizophr Res. 2015 Aug 6. pii: S0920-9964(15)00361.
    PubMed     Text format     Abstract available


  575. POTVIN S, Tikasz A, Lungu O, Dumais A, et al
    Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: An fMRI study.
    Schizophr Res. 2015 Aug 5. pii: S0920-9964(15)00412.
    PubMed     Text format     Abstract available


  576. BERRY C, Greenwood K
    Hope-inspiring therapeutic relationships, professional expectations and social inclusion for young people with psychosis.
    Schizophr Res. 2015 Aug 4. pii: S0920-9964(15)00397.
    PubMed     Text format     Abstract available


  577. HASHIOKA S, McGeer PL, Miyaoka T, Wake R, et al
    Can inhibition of microglial activation cure schizophrenia?
    Schizophr Res. 2015 Aug 4. pii: S0920-9964(15)00408.
    PubMed     Text format    


    July 2015
  578. ALLEN KM, Purves-Tyson TD, Shannon Weickert C
    Reproductive hormones and schizophrenia.
    Schizophr Res. 2015 Jul 31. pii: S0920-9964(15)00399.
    PubMed     Text format    


  579. BLANCHARD JJ, Park SG, Catalano LT, Bennett ME, et al
    Social affiliation and negative symptoms in schizophrenia: Examining the role of behavioral skills and subjective responding.
    Schizophr Res. 2015 Jul 31. pii: S0920-9964(15)00384.
    PubMed     Text format     Abstract available


  580. POWER BD, Dragovic M, Badcock JC, Morgan VA, et al
    No additive effect of cannabis on cognition in schizophrenia.
    Schizophr Res. 2015 Jul 30. pii: S0920-9964(15)00356.
    PubMed     Text format     Abstract available


  581. CHANG WC, Cheung R, Hui CL, Lin J, et al
    Rate and risk factors of depressive symptoms in Chinese patients presenting with first-episode non-affective psychosis in Hong Kong.
    Schizophr Res. 2015 Jul 30. pii: S0920-9964(15)00406.
    PubMed     Text format     Abstract available


  582. WATKINS CC, Andrews SR
    Clinical studies of neuroinflammatory mechanisms in schizophrenia.
    Schizophr Res. 2015 Jul 30. pii: S0920-9964(15)00362.
    PubMed     Text format     Abstract available


  583. PARK YM, Jung E, Kim HS, Hahn SW, et al
    Differences in central serotoninergic transmission among patients with recent onset, sub-chronic, and chronic schizophrenia as assessed by the loudness dependence of auditory evoked potentials.
    Schizophr Res. 2015 Jul 29. pii: S0920-9964(15)00402.
    PubMed     Text format     Abstract available


  584. LIN PY
    Shortened leukocyte telomere length in patients with schizophrenia is related to disease status.
    Schizophr Res. 2015 Jul 29. pii: S0920-9964(15)00404.
    PubMed     Text format    


  585. TANG Y, Chen K, Zhou Y, Liu J, et al
    Neural activity changes in unaffected children of patients with schizophrenia: A resting-state fMRI study.
    Schizophr Res. 2015 Jul 29. pii: S0920-9964(15)00390.
    PubMed     Text format     Abstract available


  586. MORRIS RW, Purves-Tyson TD, Weickert CS, Rothmond D, et al
    Testosterone and reward prediction-errors in healthy men and men with schizophrenia.
    Schizophr Res. 2015 Jul 29. pii: S0920-9964(15)00400.
    PubMed     Text format     Abstract available


  587. O'DONOGHUE B, Lyne J, Madigan K, Lane A, et al
    Environmental factors and the age at onset in first episode psychosis.
    Schizophr Res. 2015 Jul 28. pii: S0920-9964(15)00343.
    PubMed     Text format     Abstract available


  588. TABAK NT, Horan WP, Green MF
    Mindfulness in schizophrenia: Associations with self-reported motivation, emotion regulation, dysfunctional attitudes, and negative symptoms.
    Schizophr Res. 2015 Jul 28. pii: S0920-9964(15)00395.
    PubMed     Text format     Abstract available


  589. NABER D, Hansen K, Forray C, Baker RA, et al
    Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia.
    Schizophr Res. 2015 Jul 28. pii: S0920-9964(15)00346.
    PubMed     Text format     Abstract available


  590. PALANIYAPPAN L, Mahmood J, Balain V, Mougin O, et al
    Structural correlates of formal thought disorder in schizophrenia: An ultra-high field multivariate morphometry study.
    Schizophr Res. 2015 Jul 28. pii: S0920-9964(15)00387.
    PubMed     Text format     Abstract available


  591. MOHRING N, Shen C, Hahn E, Ta TM, et al
    Mirror neuron deficit in schizophrenia: Evidence from repetition suppression.
    Schizophr Res. 2015 Jul 28. pii: S0920-9964(15)00401.
    PubMed     Text format     Abstract available


  592. CASTRO J, Zanini M, Goncalves BD, Coelho FM, et al
    Circadian rest-activity rhythm in individuals at risk for psychosis and bipolar disorder.
    Schizophr Res. 2015 Jul 25. pii: S0920-9964(15)00389.
    PubMed     Text format     Abstract available


  593. HEDMAN AM, van Haren NE, van Baal GC, Brouwer RM, et al
    Heritability of cortical thickness changes over time in twin pairs discordant for schizophrenia.
    Schizophr Res. 2015 Jul 24. pii: S0920-9964(15)00336.
    PubMed     Text format     Abstract available


  594. FERVAHA G, Duncan M, Foussias G, Agid O, et al
    Effort-based decision making as an objective paradigm for the assessment of motivational deficits in schizophrenia.
    Schizophr Res. 2015 Jul 24. pii: S0920-9964(15)00388.
    PubMed     Text format     Abstract available


  595. ALDEN EC, Cobia DJ, Reilly JL, Smith MJ, et al
    Cluster analysis differentiates high and low community functioning in schizophrenia: Subgroups differ on working memory but not other neurocognitive domains.
    Schizophr Res. 2015 Jul 24. pii: S0920-9964(15)00350.
    PubMed     Text format     Abstract available


  596. KRANZ TM, Goetz RR, Walsh-Messinger J, Goetz D, et al
    Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk.
    Schizophr Res. 2015 Jul 24. pii: S0920-9964(15)00341.
    PubMed     Text format     Abstract available


  597. BHAVSAR V
    Regarding Trauelsen et al. 2015: General versus specific adversity in aetiological research into psychosis.
    Schizophr Res. 2015 Jul 24. pii: S0920-9964(15)00355.
    PubMed     Text format    


  598. HUR JW, Choi SH, Yun JY, Chon MW, et al
    Parental socioeconomic status and prognosis in individuals with ultra-high risk for psychosis: A 2-year follow-up study.
    Schizophr Res. 2015 Jul 24. pii: S0920-9964(15)00385.
    PubMed     Text format     Abstract available


  599. SCHIFFMAN J, Kline E, Jameson ND, Sorensen HJ, et al
    Premorbid multivariate prediction of adult psychosis-spectrum disorder: A high-risk prospective investigation.
    Schizophr Res. 2015 Jul 23. pii: S0920-9964(15)00353.
    PubMed     Text format     Abstract available


  600. HOU PY, Hung GC, Jhong JR, Tsai SY, et al
    Risk factors for sudden cardiac death among patients with schizophrenia.
    Schizophr Res. 2015 Jul 22. pii: S0920-9964(15)00354.
    PubMed     Text format     Abstract available


  601. ROBERTS RC, Barksdale KA, Roche JK, Lahti AC, et al
    Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.
    Schizophr Res. 2015 Jul 22. pii: S0920-9964(15)00360.
    PubMed     Text format     Abstract available


  602. COMPTON MT, Bakeman R, Alolayan Y, Balducci PM, et al
    Personality domains, duration of untreated psychosis, functioning, and symptom severity in first-episode psychosis.
    Schizophr Res. 2015 Jul 22. pii: S0920-9964(15)00358.
    PubMed     Text format     Abstract available


  603. HEMMERLE AM, Ahlbrand R, Bronson SL, Lundgren KH, et al
    Modulation of schizophrenia-related genes in the forebrain of adolescent and adult rats exposed to maternal immune activation.
    Schizophr Res. 2015 Jul 20. pii: S0920-9964(15)00345.
    PubMed     Text format     Abstract available


  604. JACOBS BM
    A dangerous method? The use of induced pluripotent stem cells as a model for schizophrenia.
    Schizophr Res. 2015 Jul 17. pii: S0920-9964(15)00344.
    PubMed     Text format     Abstract available


  605. DE CAMPOS SM, Barbosa IG, Ribeiro-Santos R, Ferretjans R, et al
    Procalcitonin levels in schizophrenic patients and patients with sepsis.
    Schizophr Res. 2015 Jul 17. pii: S0920-9964(15)00349.
    PubMed     Text format    


  606. CASTRO MN, Villarreal MF, Bolotinsky N, Papavero E, et al
    Brain activation induced by psychological stress in patients with schizophrenia.
    Schizophr Res. 2015 Jul 16. pii: S0920-9964(15)00347.
    PubMed     Text format     Abstract available


  607. SMITH RC, Boules S, Mattiuz S, Youssef M, et al
    Effects of transcranial direct current stimulation (tDCS) on cognition, symptoms, and smoking in schizophrenia: A randomized controlled study.
    Schizophr Res. 2015 Jul 16. pii: S0920-9964(15)00326.
    PubMed     Text format     Abstract available


  608. STUBBS B, Gardner-Sood P, Smith S, Ismail K, et al
    Sedentary behaviour is associated with elevated C-reactive protein levels in people with psychosis.
    Schizophr Res. 2015 Jul 15. pii: S0920-9964(15)00342.
    PubMed     Text format     Abstract available


  609. SPILKA MJ, Arnold AE, Goghari VM
    Functional activation abnormalities during facial emotion perception in schizophrenia patients and nonpsychotic relatives.
    Schizophr Res. 2015 Jul 15. pii: S0920-9964(15)00351.
    PubMed     Text format     Abstract available


  610. GUO JY, Huhtaniska S, Miettunen J, Jaaskelainen E, et al
    Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function.
    Schizophr Res. 2015 Jul 15. pii: S0920-9964(15)00331.
    PubMed     Text format     Abstract available


  611. DALTIO CS, Attux C, Ferraz MB
    Knowledge in schizophrenia: The Portuguese version of KAST (Knowledge About Schizophrenia Test) and analysis of social-demographic and clinical factors' influence.
    Schizophr Res. 2015 Jul 15. pii: S0920-9964(15)00348.
    PubMed     Text format     Abstract available


  612. RENWICK L, Lyne J, Donoghue BO, Owens L, et al
    Prodromal symptoms and remission following first episode psychosis.
    Schizophr Res. 2015 Jul 14. pii: S0920-9964(15)00340.
    PubMed     Text format     Abstract available


  613. DLABAC-DE LANGE JJ, Liemburg EJ, Bais L, Renken RJ, et al
    Effect of rTMS on brain activation in schizophrenia with negative symptoms: A proof-of-principle study.
    Schizophr Res. 2015 Jul 14. pii: S0920-9964(15)00333.
    PubMed     Text format     Abstract available


  614. WANG J, Huang J, Yang XH, Lui SS, et al
    Anhedonia in schizophrenia: Deficits in both motivation and hedonic capacity.
    Schizophr Res. 2015 Jul 13. pii: S0920-9964(15)00334.
    PubMed     Text format     Abstract available


  615. MANSCHRECK TC, Chun J, Merrill AM, Maher BA, et al
    Impaired motor performance in adolescents at familial high-risk for schizophrenia.
    Schizophr Res. 2015 Jul 9. pii: S0920-9964(15)00328.
    PubMed     Text format     Abstract available


  616. LYSAKER PH, Kukla M, Dubreucq J, Gumley A, et al
    Metacognitive deficits predict future levels of negative symptoms in schizophrenia controlling for neurocognition, affect recognition, and self-expectation of goal attainment.
    Schizophr Res. 2015 Jul 8. pii: S0920-9964(15)00330.
    PubMed     Text format     Abstract available


  617. NENADIC I, Lorenz C, Langbein K, Dietzek M, et al
    Brain structural correlates of schizotypy and psychosis proneness in a non-clinical healthy volunteer sample.
    Schizophr Res. 2015 Jul 8. pii: S0920-9964(15)00332.
    PubMed     Text format     Abstract available


  618. GOLDSTEIN MR, Peterson MJ, Sanguinetti JL, Tononi G, et al
    Topographic deficits in alpha-range resting EEG activity and steady state visual evoked responses in schizophrenia.
    Schizophr Res. 2015 Jul 6. pii: S0920-9964(15)00327.
    PubMed     Text format     Abstract available


  619. GUASTELLA AJ, Ward PB, Hickie IB, Shahrestani S, et al
    A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.
    Schizophr Res. 2015 Jul 3. pii: S0920-9964(15)00320.
    PubMed     Text format     Abstract available


  620. TRAUELSEN AM, Bendall S, Jansen JE, Nielsen HL, et al
    Severity and persistence versus type of childhood adversity in non-affective first-episode psychosis.
    Schizophr Res. 2015 Jul 2. pii: S0920-9964(15)00335.
    PubMed     Text format    


  621. SMITH KP, Penzner JB
    Mutism in non-catatonic schizophrenia: Psychotic symptom and adaptive behavioral strategy.
    Schizophr Res. 2015 Jul 2. pii: S0920-9964(15)00325.
    PubMed     Text format     Abstract available


  622. CHEN X, Duan M, Xie Q, Lai Y, et al
    Functional disconnection between the visual cortex and the sensorimotor cortex suggests a potential mechanism for self-disorder in schizophrenia.
    Schizophr Res. 2015 Jul 1. pii: S0920-9964(15)00329.
    PubMed     Text format     Abstract available


  623. NICOTRA E, Casu G, Piras S, Marchese G, et al
    On the use of the Positive and Negative Syndrome Scale in randomized clinical trials.
    Schizophr Res. 2015;165.
    PubMed     Text format     Abstract available


    June 2015
  624. CONSTANTINE RJ, Andel R, McPherson M, Tandon R, et al
    The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: A randomized controlled trial.
    Schizophr Res. 2015 Jun 30. pii: S0920-9964(15)00311.
    PubMed     Text format     Abstract available


  625. LLOYD K, McGregor J, John A, Craddock N, et al
    A national population-based e-cohort of people with psychosis (PsyCymru) linking prospectively ascertained phenotypically rich and genetic data to routinely collected records: Overview, recruitment and linkage.
    Schizophr Res. 2015 Jun 29. pii: S0920-9964(15)00309.
    PubMed     Text format     Abstract available


  626. BARTHOLOMEUSZ CF, Ganella EP, Labuschagne I, Bousman C, et al
    Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia.
    Schizophr Res. 2015 Jun 26. pii: S0920-9964(15)00322.
    PubMed     Text format     Abstract available


  627. BRINHOLI FF, Noto C, Maes M, Bonifacio KL, et al
    Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naive first episode psychosis.
    Schizophr Res. 2015 Jun 26. pii: S0920-9964(15)00324.
    PubMed     Text format     Abstract available


  628. HARVEY PD, Siu CO, Ogasa M, Loebel A, et al
    Effect of lurasidone dose on cognition in patients with schizophrenia: Post-hoc analysis of a long-term, double-blind continuation study.
    Schizophr Res. 2015 Jun 24. pii: S0920-9964(15)00323.
    PubMed     Text format     Abstract available


  629. MARTINELLI C, Shergill SS
    Clarifying the role of pattern separation in schizophrenia: The role of recognition and visual discrimination deficits.
    Schizophr Res. 2015 Jun 24. pii: S0920-9964(15)00319.
    PubMed     Text format     Abstract available


  630. MASSE M, Lecomte T
    Metacognitive profiles in individuals with a first episode of psychosis and their relation to social functioning and perceived social support.
    Schizophr Res. 2015 Jun 23. pii: S0920-9964(15)00277.
    PubMed     Text format     Abstract available


  631. KIPPE JM, Mueller TM, Haroutunian V, Meador-Woodruff JH, et al
    Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia.
    Schizophr Res. 2015 Jun 20. pii: S0920-9964(15)00317.
    PubMed     Text format     Abstract available


  632. CZEPIELEWSKI LS, Sodre L, Souza AC, Bucker J, et al
    Changes in verbal learning of patients with schizophrenia: Results from a randomized, double-blind, placebo-controlled trial of amantadine adjunctive to antipsychotics.
    Schizophr Res. 2015 Jun 20. pii: S0920-9964(15)00316.
    PubMed     Text format    


  633. PALMER EC, Gilleen J, David AS
    The relationship between cognitive insight and depression in psychosis and schizophrenia: A review and meta-analysis.
    Schizophr Res. 2015 Jun 18. pii: S0920-9964(15)00289.
    PubMed     Text format     Abstract available


  634. GUR RE, March M, Calkins ME, Weittenhiller L, et al
    Negative symptoms in youths with psychosis spectrum features: Complementary scales in relation to neurocognitive performance and function.
    Schizophr Res. 2015 Jun 17. pii: S0920-9964(15)00310.
    PubMed     Text format     Abstract available


  635. KRANZ TM, Harroch S, Manor O, Lichtenberg P, et al
    De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample.
    Schizophr Res. 2015 Jun 16. pii: S0920-9964(15)00315.
    PubMed     Text format     Abstract available


  636. TU PC, Lee YC, Chen YS, Hsu JW, et al
    Network-specific cortico-thalamic dysconnection in schizophrenia revealed by intrinsic functional connectivity analyses.
    Schizophr Res. 2015 Jun 13. pii: S0920-9964(15)00280.
    PubMed     Text format     Abstract available


  637. FARKAS K, Stefanics G, Marosi C, Csukly G, et al
    Elementary sensory deficits in schizophrenia indexed by impaired visual mismatch negativity.
    Schizophr Res. 2015 Jun 11. pii: S0920-9964(15)00268.
    PubMed     Text format     Abstract available


  638. RUDOLPH ED, Ells EM, Campbell DJ, Abriel SC, et al
    Finding the missing-stimulus mismatch negativity (MMN) in early psychosis: Altered MMN to violations of an auditory gestalt.
    Schizophr Res. 2015 Jun 10. pii: S0920-9964(15)00285.
    PubMed     Text format     Abstract available


  639. LI Z, Lui SS, Geng FL, Li Y, et al
    Experiential pleasure deficits in different stages of schizophrenia.
    Schizophr Res. 2015 Jun 10. pii: S0920-9964(15)00314.
    PubMed     Text format     Abstract available


  640. HADAR R, Soto-Montenegro ML, Gotz T, Wieske F, et al
    Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course.
    Schizophr Res. 2015 Jun 5. pii: S0920-9964(15)00267.
    PubMed     Text format     Abstract available


  641. HO KK, Lui SS, Hung KS, Wang Y, et al
    Theory of mind impairments in patients with first-episode schizophrenia and their unaffected siblings.
    Schizophr Res. 2015 Jun 3. pii: S0920-9964(15)00290.
    PubMed     Text format     Abstract available


  642. PASTERNAK O, Kubicki M, Shenton ME
    In vivo imaging of neuroinflammation in schizophrenia.
    Schizophr Res. 2015 Jun 2. pii: S0920-9964(15)00307.
    PubMed     Text format     Abstract available


  643. MATOSIN N, Fernandez-Enright F, Lum JS, Andrews JL, et al
    Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia.
    Schizophr Res. 2015 Jun 2. pii: S0920-9964(15)00239.
    PubMed     Text format     Abstract available


  644. AU DW, Tsang HW, So WW, Bell MD, et al
    Effects of integrated supported employment plus cognitive remediation training for people with schizophrenia and schizoaffective disorders.
    Schizophr Res. 2015 Jun 1. pii: S0920-9964(15)00270.
    PubMed     Text format     Abstract available


  645. GLICK HA, Li P, Harvey PD
    The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: An analysis of the CATIE Schizophrenia Trial.
    Schizophr Res. 2015 Jun 1. pii: S0920-9964(15)00278.
    PubMed     Text format     Abstract available


  646. GARCIA-PORTILLA MP, Garcia-Alvarez L, Mane A, Garcia-Rizo C, et al
    The negative syndrome of schizophrenia: Three -underlying components are better than two.
    Schizophr Res. 2015 Jun 1. pii: S0920-9964(15)00259.
    PubMed     Text format     Abstract available


    May 2015
  647. PURCELL R, Harrigan S, Glozier N, Amminger GP, et al
    Self reported rates of criminal offending and victimization in young people at-risk for psychosis.
    Schizophr Res. 2015 May 30. pii: S0920-9964(15)00281.
    PubMed     Text format     Abstract available


  648. RUSCH N, Heekeren K, Theodoridou A, Muller M, et al
    Stigma as a stressor and transition to schizophrenia after one year among young people at risk of psychosis.
    Schizophr Res. 2015 May 30. pii: S0920-9964(15)00284.
    PubMed     Text format     Abstract available


  649. KURIMORI M, Shiozawa P, Bikson M, Aboseria M, et al
    Targeting negative symptoms in schizophrenia: Results from a proof-of-concept trial assessing prefrontal anodic tDCS protocol.
    Schizophr Res. 2015 May 29. pii: S0920-9964(15)00286.
    PubMed     Text format    


  650. SMITH MJ, Fleming MF, Wright MA, Roberts AG, et al
    Virtual reality job interview training and 6-month employment outcomes for individuals with schizophrenia seeking employment.
    Schizophr Res. 2015 May 29. pii: S0920-9964(15)00279.
    PubMed     Text format     Abstract available


  651. CROPLEY VL, Lin A, Nelson B, Reniers RL, et al
    Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.
    Schizophr Res. 2015 May 29. pii: S0920-9964(15)00271.
    PubMed     Text format     Abstract available


  652. NASRALLAH HA, Harvey PD, Casey D, Csoboth CT, et al
    The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: A focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization.
    Schizophr Res. 2015 May 28. pii: S0920-9964(15)00226.
    PubMed     Text format     Abstract available


  653. ALVAREZ-JIMENEZ M, Alcazar-Corcoles MA, Gonzalez-Blanch C, Bendall S, et al
    Online social media: New data, new horizons in psychosis treatment.
    Schizophr Res. 2015 May 26. pii: S0920-9964(15)00263.
    PubMed     Text format    


  654. CHESLACK-POSTAVA K, Brown AS, Chudal R, Suominen A, et al
    Maternal exposure to sexually transmitted infections and schizophrenia among offspring.
    Schizophr Res. 2015 May 25. pii: S0920-9964(15)00269.
    PubMed     Text format     Abstract available


  655. GOMES FG, Passos IC, Krolow AC, Reckziegel R, et al
    Differences in parental bonding between schizophrenia and bipolar disorder: Evidence of prodromal symptoms?
    Schizophr Res. 2015 May 24. pii: S0920-9964(15)00169.
    PubMed     Text format     Abstract available


  656. KRISTIAN HILL S, Buchholz A, Amsbaugh H, Reilly JL, et al
    Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment.
    Schizophr Res. 2015 May 22. pii: S0920-9964(15)00275.
    PubMed     Text format     Abstract available


  657. DOLD M, Fugger G, Aigner M, Lanzenberger R, et al
    Dose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials.
    Schizophr Res. 2015 May 22. pii: S0920-9964(15)00219.
    PubMed     Text format     Abstract available


  658. FOUSSIAS G, Siddiqui I, Fervaha G, Mann S, et al
    Motivated to do well: An examination of the relationships between motivation, effort, and cognitive performance in schizophrenia.
    Schizophr Res. 2015 May 22. pii: S0920-9964(15)00276.
    PubMed     Text format     Abstract available


  659. CANUTI M, Buka S, Jazaeri Farsani SM, Oude Munnink BB, et al
    Reduced maternal levels of common viruses during pregnancy predict offspring psychosis: Potential role of enhanced maternal immune activity?
    Schizophr Res. 2015 May 21. pii: S0920-9964(15)00232.
    PubMed     Text format     Abstract available


  660. FERVAHA G, Hill C, Agid O, Takeuchi H, et al
    Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Schizophr Res. 2015 May 21. pii: S0920-9964(15)00272.
    PubMed     Text format     Abstract available


  661. BUCHY L, Hawco C, Joober R, Malla A, et al
    Cognitive insight in first-episode schizophrenia: Further evidence for a role of the ventrolateral prefrontal cortex.
    Schizophr Res. 2015 May 21. pii: S0920-9964(15)00266.
    PubMed     Text format     Abstract available


  662. GONZALEZ-HERNANDEZ JA, Pita-Alcorta C, Wolters CH, Padron A, et al
    Specificity and sensitivity of visual evoked potentials in the diagnosis of schizophrenia: Rethinking VEPs.
    Schizophr Res. 2015 May 21. pii: S0920-9964(15)00264.
    PubMed     Text format     Abstract available


  663. WOOD PL, Holderman NR
    Dysfunctional glycosynapses in schizophrenia: Disease and regional specificity.
    Schizophr Res. 2015 May 21. pii: S0920-9964(15)00274.
    PubMed     Text format     Abstract available


  664. KOOLA MM, Duncan EJ
    Cytokines in schizophrenia: Methodological Issues.
    Schizophr Res. 2015 May 21. pii: S0920-9964(15)00262.
    PubMed     Text format    


  665. RAO SQ, Hu HL, Ye N, Shen Y, et al
    Genetic variants in long non-coding RNA MIAT contribute to risk of paranoid schizophrenia in a Chinese Han population.
    Schizophr Res. 2015 May 21. pii: S0920-9964(15)00227.
    PubMed     Text format     Abstract available


  666. TOMIMATSU Y, Hibino R, Ohta H
    Brown Norway rats, a putative schizophrenia model, show increased electroencephalographic activity at rest and decreased event-related potential amplitude, power, and coherence in the auditory sensory gating paradigm.
    Schizophr Res. 2015 May 21. pii: S0920-9964(15)00240.
    PubMed     Text format     Abstract available


  667. ENEZ DARCIN A, Yalcin Cavus S, Dilbaz N, Kaya H, et al
    Metabolic syndrome in drug-naive and drug-free patients with schizophrenia and in their siblings.
    Schizophr Res. 2015 May 21. pii: S0920-9964(15)00260.
    PubMed     Text format     Abstract available


  668. FRAU R, Abbiati F, Bini V, Casti A, et al
    Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress.
    Schizophr Res. 2015 May 18. pii: S0920-9964(15)00261.
    PubMed     Text format     Abstract available


  669. TESLER N, Gerstenberg M, Franscini M, Jenni OG, et al
    Reduced sleep spindle density in early onset schizophrenia: A preliminary finding.
    Schizophr Res. 2015 May 18. pii: S0920-9964(15)00237.
    PubMed     Text format    


  670. SMIESKOVA R, Roiser JP, Chaddock CA, Schmidt A, et al
    Modulation of motivational salience processing during the early stages of psychosis.
    Schizophr Res. 2015 May 18. pii: S0920-9964(15)00231.
    PubMed     Text format     Abstract available


  671. RUBIN LH, Carter CS, Drogos LL, Pournajafi-Nazarloo H, et al
    Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia.
    Schizophr Res. 2015 May 16. pii: S0920-9964(15)00234.
    PubMed     Text format     Abstract available


  672. MURRAY C, Cosgrove D, Corvin A, Gill M, et al
    Greater number of older siblings is associated with decreased theory of mind ability in psychosis.
    Schizophr Res. 2015 May 15. pii: S0920-9964(15)00173.
    PubMed     Text format    


  673. CAROL EE, Mittal VA
    Normative adolescent experiences may confound assessment of positive symptoms in youth at ultra-high risk for psychosis.
    Schizophr Res. 2015 May 15. pii: S0920-9964(15)00238.
    PubMed     Text format    


  674. BARBERO JD, Gutierrez-Zotes A, Montalvo I, Creus M, et al
    Free thyroxine levels are associated with cognitive abilities in subjects with early psychosis.
    Schizophr Res. 2015 May 14. pii: S0920-9964(15)00225.
    PubMed     Text format     Abstract available


  675. OH H, DeVylder J
    Possibilities and challenges of online, social media, and mobile technologies for psychosis treatment.
    Schizophr Res. 2015 May 14. pii: S0920-9964(15)00265.
    PubMed     Text format    


  676. FERVAHA G, Foussias G, Agid O, Remington G, et al
    Motivational deficits in early schizophrenia: Prevalent, persistent, and key determinants of functional outcome.
    Schizophr Res. 2015 May 14. pii: S0920-9964(15)00235.
    PubMed     Text format     Abstract available


  677. SIMEONOVA DI, Lee FJ, Walker EF
    Longitudinal investigation of the relationship between family history of psychosis and affective disorders and Child Behavior Checklist ratings in clinical high-risk adolescents.
    Schizophr Res. 2015 May 14. pii: S0920-9964(15)00222.
    PubMed     Text format     Abstract available


  678. GUO W, Liu F, Xiao C, Liu J, et al
    Increased short-range and long-range functional connectivity in first-episode, medication-naive schizophrenia at rest.
    Schizophr Res. 2015 May 13. pii: S0920-9964(15)00229.
    PubMed     Text format     Abstract available


  679. KLINE E, Thompson E, Demro C, Bussell K, et al
    Longitudinal validation of psychosis risk screening tools.
    Schizophr Res. 2015 May 11. pii: S0920-9964(15)00221.
    PubMed     Text format     Abstract available


  680. POLHO GB, De-Paula VJ, Cardillo G, Dos Santos B, et al
    Leukocyte telomere length in patients with schizophrenia: A meta-analysis.
    Schizophr Res. 2015 May 11. pii: S0920-9964(15)00220.
    PubMed     Text format     Abstract available


  681. GILL KE, Quintero JM, Poe SL, Moreira AD, et al
    Assessing suicidal ideation in individuals at clinical high risk for psychosis.
    Schizophr Res. 2015 May 7. pii: S0920-9964(15)00217.
    PubMed     Text format     Abstract available


  682. KASTER TS, de Jesus D, Radhu N, Farzan F, et al
    Clozapine potentiation of GABA mediated cortical inhibition in treatment resistant schizophrenia.
    Schizophr Res. 2015 May 6. pii: S0920-9964(15)00188.
    PubMed     Text format     Abstract available


  683. SHAD MU, Keshavan MS
    Neurobiology of insight deficits in schizophrenia: An fMRI study.
    Schizophr Res. 2015 May 6. pii: S0920-9964(15)00216.
    PubMed     Text format     Abstract available


  684. FALCONE MA, Murray RM, O'Connor JA, Hockey LN, et al
    Jumping to conclusions and the persistence of delusional beliefs in first episode psychosis.
    Schizophr Res. 2015 May 5. pii: S0920-9964(15)00210.
    PubMed     Text format     Abstract available


  685. HOPE S, Hoseth E, Dieset I, Morch RH, et al
    Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls.
    Schizophr Res. 2015 May 5. pii: S0920-9964(15)00177.
    PubMed     Text format     Abstract available


  686. ROSENSTEIN M, Foltz PW, DeLisi LE, Elvevag B, et al
    Language as a biomarker in those at high-risk for psychosis.
    Schizophr Res. 2015 May 5. pii: S0920-9964(15)00218.
    PubMed     Text format    


  687. FOLSOM TD, Thuras PD, Fatemi SH
    Protein expression of targets of the FMRP regulon is altered in brains of subjects with schizophrenia and mood disorders.
    Schizophr Res. 2015 May 5. pii: S0920-9964(15)00185.
    PubMed     Text format     Abstract available


  688. KIM M, Lee TY, Lee S, Kim SN, et al
    Auditory P300 as a predictor of short-term prognosis in subjects at clinical high risk for psychosis.
    Schizophr Res. 2015 May 5. pii: S0920-9964(15)00228.
    PubMed     Text format     Abstract available


  689. RAMANATHAN S, Miewald J, Montrose D, Keshavan MS, et al
    Can age at sexual maturity act as a predictive biomarker for prodromal negative symptoms?
    Schizophr Res. 2015;164.
    PubMed     Text format     Abstract available


    March 2015
  690. SUN Y, Hu D, Liang J, Bao YP, et al
    Association between variants of zinc finger genes and psychiatric disorders: systematic review and meta-analysis.
    Schizophr Res. 2015;162.
    PubMed     Text format     Abstract available


  691. TAKAGI S, Balu DT, Coyle JT
    Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice.
    Schizophr Res. 2015;162.
    PubMed     Text format     Abstract available


    February 2015
  692. JOHNSON KL, Desmarais SL, Swartz MS, Van Dorn RA, et al
    Latent class analysis of discordance between results of drug use assessments in the CATIE data.
    Schizophr Res. 2015;161.
    PubMed     Text format     Abstract available


  693. BASKAK B, Baran Z, Ozguven HD, Karaboga I, et al
    Prefrontal activity measured by functional near infrared spectroscopy during probabilistic inference in subjects with persecutory delusions.
    Schizophr Res. 2015;161.
    PubMed     Text format     Abstract available


    January 2015
  694. KUBICKI M, Shenton ME
    Editorial to special issue on "white matter pathology".
    Schizophr Res. 2015;161:1-3.
    PubMed     Text format    


    December 2014
  695. EMSLEY R, Chiliza B, Asmal L, du Plessis S, et al
    Re: Less is more.
    Schizophr Res. 2014;160.
    PubMed     Text format    


  696. SEYBOLT SE
    Less is more.
    Schizophr Res. 2014;160.
    PubMed     Text format    


    September 2014
  697. YUM SK, Kim T, Hwang MY
    Polycystic ovaries is a disproportionate signal in pharmacovigilance data mining of second generation antipsychotics.
    Schizophr Res. 2014;158.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: